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CHAPTER I 
 
INTRODUCTION 
 
Implantation is a process by which the blastocyst comes into intimate 
physical and physiological contact with the uterine endometrium.  A two-way 
interaction between the implantation-competent blastocyst and receptive uterine 
luminal epithelium initiates this process (Dey et al., 2004; Wang and Dey, 2006).  
If an appropriate embryo-uterine dialogue at the molecular and cellular level is 
not established, the blastocyst will not implant leading to pregnancy failure.  
Coordinated effects of the ovarian steroid hormones estrogen and progesterone 
(P4) guide these embryo-uterine interactions that are not only critical for 
determining correct implantation timing, but also for sustaining pregnancy.  An 
increased understanding of mammalian implantation and pregnancy 
maintenance has been gained through the use of various genetically engineered 
mouse models, and this information will potentially lead to strategies to correct 
implantation failure and improve pregnancy rates in women.   
 The assembly of new life begins with the union between a sperm and an 
egg through the process of fertilization.  The one-cell fertilized egg, termed 
embryo, undergoes several mitotic cell divisions, ultimately forming a ball of cells 
(16 cells or more) termed morula.  The morula then differentiates into a 
blastocyst with two distinct cell populations, the inner cell mass (ICM) which will 
become the embryo proper and a layer of trophectoderm cells surrounding the 
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ICM which will form the placenta and extraembryonic membranes (Dey et al., 
2004).  Dysregulation of events prior, during, or after implantation can contribute 
to poor pregnancy rates in eutherian mammals.  For example, for a successful 
pregnancy to occur, on the embryonic side, fertilized eggs must develop to 
blastocysts, transit through the oviduct to the uterus, establish an intimate 
contact with the uterine epithelium, be nurtured through embryogenesis, and 
ultimately delivered at birth.  On the maternal side, the uterus must be receptive 
for implantation and undergo extensive remodeling for decidualization, 
pregnancy maintenance, and ultimately parturition (Dey, 1996; Dey et al., 2004).  
Therefore, studying implantation physiology and revealing the signaling pathways 
involved are necessary for alleviating problems with human infertility and 
ensuring the birth of quality offspring.   
 
Stages of Embryo Implantation 
Enders and Schlafke have classified the implantation process into three 
stages: apposition, adhesion, and penetration (Enders, 1976; Enders and 
Schlafke, 1969).  Apposition is the stage when embryonic trophectoderm cells 
become closely apposed to the uterine luminal epithelium.  This is followed by 
adhesion of the trophectoderm to the luminal epithelium.  Ultimate attachment 
and penetration involves the invasion of the luminal epithelium by the 
trophectoderm. 
The attachment reaction coincides with a localized increase in stromal 
vascular permeability at the site of the blastocyst, which can be demarcated by 
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intravenous injection of a macromolecular blue dye, also referred to as the 
uterine blue reaction (Psychoyos, 1973a).  This is preceded by uterine luminal 
closure, which contributes to the intimate apposition of the blastocyst with the 
uterine epithelium (Enders, 1976; Psychoyos, 1973a).  The first sign of the 
attachment reaction in the mouse occurs on the evening (2000-2400 h) of day 4 
of pregnancy (day 1 = vaginal plug) (Psychoyos, 1973a).    In mice and humans, 
while luminal epithelial cells undergo apoptosis after attachment (Parr et al., 
1987), stromal cells surrounding the implanting blastocyst undergo 
decidualization eventually embedding the embryo within the antimesometrial 
stroma.  In mice, blastocysts are oriented with their ICMs directed mesometrially, 
whereas in humans the ICM is directed antimesometrially (Dey et al., 2004).  The 
mechanism by which the blastocyst is directed to the antimesometrial luminal 
epithelium or by which the orientation of the blastocyst is achieved at the time of 
implantation remains unknown. This introduction highlights the more recently 
defined signaling cascades involved in implantation, with specific regard to P4 
signaling, therefore focusing specifically on steroid hormones, homeotic 
transcription factors, and immunophilins.   
 
Steroid hormonal regulation of early pregnancy 
 The uterus is comprised of heterogeneous cell types (luminal and 
glandular epithelium, stroma, and myometrium) that each respond differentially to 
estrogen and P4. In mice, the coordinated effects of estrogen and P4 regulate 
proliferation and/or differentiation of uterine cells in a spatiotemporal manner to 
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govern events of early pregnancy (Huet-Hudson et al., 1989).   For example, on 
the first day of pregnancy (day 1) in mice, uterine epithelial cells undergo 
proliferation under the influence of preovulatory estrogen secretion.  Rising levels 
of P4 secreted from freshly formed corpora lutea initiate stromal cell proliferation 
from day 3 onward.  This stromal cell proliferation is further stimulated by a small 
secretion of ovarian estrogen on the morning of day 4 of pregnancy.  These 
coordinated effects of P4 and estrogen result in the cessation of uterine epithelial 
cell proliferation, initiating differentiation (Huet-Hudson et al., 1989).  During 
normal pregnancy, the presence of an active blastocyst in the uterus is the 
stimulus for the implantation reaction. After the attachment reaction is initiated on 
day 4 (2000–2400 h), stromal cells surrounding the implanting blastocyst begin to 
proliferate extensively and differentiate into decidual cells (Dey, 1996).   
 In pseudopregnant mice (female mice mated with vasectomized males), 
the steroid hormonal milieu within the uterus is similarly maintained due to the 
presence of corpora lutea.  Therefore, the sensitivity of pseudopregnant uteri to 
implantation on days 1 through 4 is quite similar to that of normal pregnancy, and 
blastocyst transfer into the uterine lumen on day 4 of pseudopregnancy provokes 
normal implantation reactions and subsequent decidualization.  Although 
blastocysts are the normal inducers of implantation events, various nonspecific 
stimuli such as intraluminal infusion of oil, air, and mechanical stimuli can also 
initiate certain aspects of the decidual cell reaction (deciduoma) in 
pseudopregnant or steroid hormonally prepared uteri (Dey, 1996).   However, 
there is evidence that uterine reactions induced by nonspecific stimuli are 
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different than those induced by blastocysts (Lundkvist and Nilsson, 1982; Paria 
et al., 2001; Tranguch et al., 2007).    
 
The window of uterine receptivity 
 Uterine sensitivity with respect to steroid hormonal requirements and 
implantation has been classified as prereceptive, receptive and nonreceptive 
(refractory) (Dey, 1996; Psychoyos, 1973b).   These phases have been defined 
by blastocyst transfer experiments in pseudopregnant uteri.  In the mouse, the 
uterus is considered prereceptive on days 1 through 3 of pregnancy or 
pseudopregnancy, fully receptive on day 4, and then progressively moves toward 
nonreceptivity thereafter.  Evidence suggests that the uterus is most receptive on 
day 4 (Paria et al., 1993), and the efficiency of implantation decreases with time 
as the uterus enters the nonreceptive phase (Song et al., 2002).   By day 6, the 
uterus is completely nonreceptive/refractory to blastocyst implantation.   
 The mouse uterus becomes receptive to blastocyst implantation only if 
exposed to a small amount of estrogen 24-48 h following P4 priming (Huet-
Hudson and Dey, 1990).   The concentration of estrogen within a very narrow 
range determines the duration of the window of uterine receptivity in mice, i.e. 
uterine receptivity remains open for an extended period at lower estrogen levels 
but rapidly closes at higher levels.  Uterine nonreceptivity induced at these higher 
estrogen levels is accompanied by aberrant uterine expression of genes, 
suggesting that careful regulation of estrogen levels could improve female fertility 
in fertility clinics (Ma et al., 2003).    
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 Another critical factor determining the window of receptivity is the state of 
activity of the blastocyst.  In mice, ovariectomy before the preimplantation 
estrogen secretion on the morning of day 4 of pregnancy induces delayed 
implantation (Paria et al., 1993; Yoshinaga and Adams, 1966).   This status can 
be maintained for many days if P4 treatment is continuously provided.  Under this 
condition, blastocysts undergo zona hatching at a slower pace, but become 
dormant without initiating the attachment reaction and the P4-primed uterus 
remains in the neutral stage.  However, a single injection of estrogen promptly 
induces blastocyst activation with the initiation of implantation in the P4-primed 
uterus.  A recent global gene expression study shows that active and dormant 
blastocysts differ at the molecular and physiological level (Hamatani et al., 2004), 
suggesting that a complex network of signaling pathways distinctly regulate 
blastocyst dormancy and activation. 
 This model of delayed implantation also occurs naturally in many 
vertebrate species, but the underlying mechanisms that direct this process differ 
depending on species (Mead, 1993).  For example, delayed implantation occurs 
during lactation after postpartum ovulation and fertilization of the egg in mice and 
rats (McLaren, 1968; Yoshinaga and Hosi, 1958).  However, termination of the 
suckling stimulus readily initiates implantation.  While many other species 
undergo obligatory seasonal delayed implantation, whether this process occurs 
in humans remains unknown.  Regardless, the delayed implantation model in 
mice has been exploited in this and other studies to better understand the 
7 
molecular signaling events that emanate from the embryo to the uterus and vice 
versa. 
 
The “ripple effect” theory 
 Recent evidence suggests that a short delay in the attachment reaction 
produces an adverse ripple effect throughout pregnancy with aberrant spacing of 
embryos, defective placentation, increased number of resorptions, and retarded 
fetal development, ultimately giving rise to a poor pregnancy outcome (Song et 
al., 2002; Wilcox et al., 1999; Ye et al., 2005).  This phenotype was shown in 
mice lacking either cytoplasmic phospholipase A2α (cPLA2α) or G-protein-coupled 
lysophosphatidic acid receptor (LPA3), illustrating the importance of these 
signaling pathways in determining the window of uterine receptivity and on-time 
implantation (Song et al., 2002; Ye et al., 2005).  Interestingly, treatment of both 
cPLA2α and Lpa3 null females with prostaglandins (PGs) resumes on-time 
implantation, but embryo crowding persists (Song et al., 2002; Ye et al., 2005).  
The phenotypic similarity between cPLA2α and Lpa3 null females and the 
reduced levels of uterine COX-2 in Lpa3 null females identifies COX-2 as a 
common signaling pathway in mediating these molecules.  Overall, this concept 
of timing as a crucial component of normal feto-placental development and 
determinant of pregnancy outcome comprises a novel theme whereby early 
embryo-uterine interaction directs developmental programming for the remainder 
of the gestation.   
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Progesterone (P4): discovering the ‘pregnancy hormone’ 
 While ovarian estrogen is essential for blastocyst implantation in the P4-
primed uterus in mice and rats, it is not essential for implantation in pigs, guinea 
pigs, rabbits or hamsters (Dey et al., 2004).  One reason for this lack of 
requirement for estrogen could be that pig and rabbit blastocysts synthesize their 
own estrogen, while mouse embryos lack such machinery.  Whereas ovarian 
estrogen is crucial in only some species, ovarian P4, on the other hand, is 
required for pregnancy maintenance in most eutherians studied.  The diverse 
actions of P4 include balancing the effects of estrogen, regulating uterine smooth 
muscle contraction until labor, and modulating maternal immunological 
surveillance towards the embryo (Tranguch et al., 2006). 
 Since the discovery of the corpus luteum in 1672 by Regner DeGraaf, a 
Dutch scientist whose namesake was given to the antral “Graafian” follicle, much 
work followed to characterize the role of this structure during pregnancy.  
DeGraaf recognized that the presence of the corpus luteum was associated with 
pregnancy (Corner, 1943; Corner, 1974) and until 1900, many functions for the 
corpus luteum were proposed.  One group postulated that its function was to 
prevent ovulation during pregnancy (August Prenant, France), while another 
group implicated its involvement in preparing the endometrium for implantation 
(Gustav Born, Germany) (Frobenius, 1999).  Prior to his death, Gustav Born had 
a revelation that the corpus luteum must secrete some substance to protect the 
embryo and support implantation (Corner, 1974).  In 1900, Ludwig Fraenkel, a 
disciple of Born, examined this hypothesis and provided proof for an endocrine 
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function of the corpus luteum, an amazing triumph considering the terms 
‘hormone’ or ‘endocrinology’ had not yet been coined.  In these experiments, 
Fraenkel used the rabbit as an animal model, a useful model since rabbits only 
ovulate post-mating with embryos residing in the oviducts and uterus for about 
seven days before implantation.  Fraenkel found that pregnancy loss occurred if 
he removed the corpora lutea within those seven days post-mating (Fraenkel, 
1903).  It was also at this time that Paul Ancel and Paul Bouin found that the 
corpus luteum was responsible for changes occurring in the endometrium in both 
pregnant and pseudopregnant rabbits (Bouin and Ancel, 1910).  From these 
experiments, it became clear that the corpus luteum does in fact secrete a 
substance to influence both the fate of the embryo and the integrity of the uterus.  
In 1934, the successful purification of this substance, progesterone, in its 
crystalline form was independently reported by several groups (Karl Slotta, Hans 
Ruschig, Eric Fels of Breslau; George W. Corner Sr. and Willard Allen of the 
United States; and Karl Butenandt and Oskar Wintersteiner of Germany) 
(Frobenius, 1999).   
 The discovery and isolation of P4 coincided with experiments by several 
groups showing that pituitary or ovarian extracts stimulate ovulation in frogs 
(Heilbrunn et al., 1939; Rugh, 1935; Ryan, 1940; Wright, 1945).  In the late 
1950s and 1960s, while researchers began to elaborate on various roles for P4 
ligand, Gerald Mueller and Elwood Jensen discovered the estrogen receptor 
(ER) (Fannon et al., 2001).  The field of steroid hormone action then quickly 
erupted when Jack Gorski and Angelo Notides linked estrogen action with uterine 
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protein synthesis (Notides and Gorski, 1966).  Soon after, nuclear progesterone 
receptor (PR) was the first steroid hormone receptor to be purified, first from the 
chick oviduct (O'Malley et al., 1970) and later from humans (Smith et al., 1975).  
After purification of PR, ER and androgen receptor (AR), it was soon realized that 
steroid hormone receptors primarily affect gene transcription (Schwartz et al., 
1977).  It was not until 1985, however, with the advent of DNA sequencing 
technology, that a steroid hormone receptor, glucocorticoid receptor (GR), was 
cloned (Weinberger et al., 1985); the cloning of the remaining steroid hormone 
receptors followed shortly after (Arriza et al., 1987; Brinkmann et al., 1989; 
Greene et al., 1986; Jeltsch et al., 1986).   
 
Mechanism of progesterone signaling 
 P4 mediates its responses primarily through its nuclear PR to activate 
transcription of genes involved in uterine biology and pregnancy.  Two isoforms 
of PR are expressed from one single gene: PRA and PRB.  These two gene 
products are transcribed from separate promoters on the same gene, with PRB 
being the longer of the two proteins (120 kDa) compared with PRA (97 kDa) 
(Figure 1).   
 
 
Figure 1. The PR gene, Pgr, encodes two isoforms, PRA and PRB, with 
separate translation initiation sites (AUG). AF, transactivation domain; DBD, 
DNA binding domain; LBD, ligand binding domain; N, amino terminal; C, 
carboxyl terminal. 
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The amino terminal portion of both isoforms is the most hypervariable region and 
contains the transactivation domains, AF3 (PRB only) and AF1 (PRA and PRB), 
responsible for the recruitment of coactivators and/or corepressors during 
transcriptional regulation.  The DNA-binding domain (DBD) is the most 
conserved region, composed of two type II zinc finger structures responsible for 
binding to specific cis-acting DNA sequences (Freedman, 1992; Luisi et al., 
1991).  The carboxyl terminal region contains the ligand-binding domain (LBD) 
with an additional site, AF2, for interaction with transcriptional coregulators.  PR 
interactions with heat shock proteins and other chaperones to localize to the 
LBD/AF2 (Schowalter et al., 1991).  The larger segment of PRB, referred to as 
the B upstream sequence (Kelleher et al., 1999), contains the AF3 domain, which 
is thought to attenuate PRB activity.  For this reason, PRB tends to be less 
transcriptionally active than the PRA isoform.  In fact, it is thought that PRA acts 
as a dominant repressor of PRB, evidenced by coexpression studies in cultured 
cells (Kraus et al., 1995; Vegeto et al., 1993).  PRA and PRB proteins also 
respond differentially to P4 antagonists, e.g. RU-486, in that antagonist-bound 
PRA is inactive, while antagonist-bound PRB has increased transcriptional 
activity (Conneely et al., 2001).  When expressed in equimolar concentrations in 
cells, PRA and PRB can homodimerize or heterodimerize, essentially existing as 
three entities: A:A, B:B, A:B.  It is thought that each entity then will exhibit 
differential activity in regulating downstream target genes. 
 Mice lacking the Pgr gene encoding both PR isoforms have illustrated the 
essential roles of P4 signaling through its nuclear steroid hormone receptor 
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during reproductive processes.  Female mice lacking both PR isoforms have 
complete ovulation, fertilization, and implantation failure as well as impaired 
sexual behavior, defective responses to gonadotropins, and defective ductal 
branching morphogenesis and lobuloalveolar differentiation of the mammary 
gland (Chappell et al., 1997; Lydon et al., 1995).  P4 signaling through PR has 
also been shown to play a role in decidualization and maintaining the uterus in a 
quiescent state until delivery (Dey et al., 2004).   
Mouse models lacking either PRA or PRB have been generated using the 
CRE-loxP system to introduce a point mutation at either of the two ATG 
translation initiation codons (Mulac-Jericevic et al., 2003; Mulac-Jericevic et al., 
2000).  While PgrA null female mice are infertile due to severe abnormalities in 
ovarian and uterine functions, PgrB null female mice show no apparent defects in 
ovarian and uterine functions but have significantly reduced mammary ductal 
side-branching and alveologenesis during pregnancy.  These findings suggest 
that PRA and PRB act in a tissue-selective manner to regulate their specific 
actions, and also imply that PRA:PRB heterodimers are not required for uterine 
reproductive events.   
It is also thought that P4 can signal through a membrane receptor; 
however, the contribution of this signaling pathway to specific physiological 
processes has not yet been conclusively demonstrated.  A role for this signaling 
was first shown in Xenopus oocytes.  Quiescent Xenopus oocytes remain 
arrested in meiosis I until exposure to P4, which triggers rapid non-transcriptional 
responses rather than the conventional transcriptional activation known to be a 
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signature of nuclear steroid hormone receptor signaling.  Using the Xenopus 
model, one study identified XPR1 as a membrane PR necessary for Xenopus 
oocyte activation (Tian et al., 2000).  Zhu and colleagues cloned a membrane 
progestin receptor from spotted sea trout ovaries, characterizing it as a G-protein 
coupled receptor expressed solely in the brain and reproductive organs that 
activates mitogen-activated protein kinase (MAPK) signaling pathways upon 
progestin binding (Zhu et al., 2003).  Since then, three forms of putative 
membrane-bound progestin receptors have been identified in channel catfish 
(mPRα, β, and γ) (Kazeto et al., 2005), and another group has identified an 
adrenal cortex protein, inner zone antigen (IZAg), as a putative membrane PR 
(Raza et al., 2001).  In the mouse, two potential membrane PRs are thought to 
play roles particularly in ovarian cells: membrane progesterone receptor (MPR) 
and PGR membrane component I (PGRMC1) (Peluso et al., 2006; Zhu et al., 
2003).  While MPRs and PGRMC1 are expressed in various cell types of the 
ovary, their roles in ovarian biology remain to be determined (Peluso et al., 
2006).  Whether a role for these membrane PRs exists in uterine biology also 
remains unexplored. 
 
Progesterone-regulated target genes during early pregnancy 
 On day 4 of pregnancy in mice, the uterus is primarily under the influence 
of P4, and P4-target genes activated through PR include homeobox transcription 
factors, growth factors, and cytokines (Dey et al., 2004). These genes show 
robust expression on this day of pregnancy.  Specific examples of P4-regulated 
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or responsive genes include amphiregulin (Areg), histidine decarboxylase (Hdc), 
Indian hedgehog (Ihh), and Hoxa-10.   
Amphiregulin is a glycosylated heparin-binding protein and a member of 
the epidermal growth factor (EGF) family.  Under the influence of P4, Areg is 
expressed in the luminal and glandular epithelia (Das et al., 1995) and is 
regulated by P4 working via the PRA isoform (Mulac-Jericevic et al., 2003).  
While amphiregulin is associated with uterine cell-specific differentiation and 
proliferation, mice lacking the Areg gene appear to have normal fertility (Luetteke 
et al., 1999).  This could result from compensation by other EGF family 
members, but precludes amphiregulin as an essential factor for implantation.  
Another P4-regulated gene upregulated by P4 working through the PRA isoform is 
histidine decarboxylase (Hdc) (Mulac-Jericevic et al., 2000).   This gene is 
expressed primarily in the epithelium on day 4 of pregnancy (Paria et al., 1998), 
but its role in implantation biology has yet to be determined. 
 The components of the hedgehog signaling pathway are influenced by P4, 
specifically those of Indian hedgehog (IHH) including the hedgehog-binding 
receptor, Patched, and its downstream transcription factor Gli1-3 (Matsumoto et 
al., 2002).  Expression of Ihh increases in the luminal and glandular epithelium 
from day 3 of pregnancy onward.  During the same time, the expression of its 
receptor and downstream transcription factors is upregulated in the underlying 
stroma. This suggests that IHH functions as a paracrine growth factor for stromal 
cell proliferation during early pregnancy.  Roles for hedgehog signaling have  
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also been delineated in cancer, and recent evidence indicates roles for this 
conserved signaling pathway in uterine biology (Lee et al., 2006).   
Hoxa10 encodes a transcription factor that belongs to a multigene family.  
Hox genes are developmentally regulated and share a common highly conserved 
sequence element called the homeobox that encodes a helix-turn-helix DNA 
binding domain (Krumlauf, 1994).  Hox genes are organized into four clusters (A, 
B, C, and D) on four different chromosomes in mice and humans and follow a 
stringent pattern of spatial and temporal colinearity during embryogenesis 
(Krumlauf, 1994).  Specifically, genes at the 3’-end of each cluster are activated 
during early embryogenesis in the anterior region of the developing embryo, 
whereas genes located toward the 5’-end are restricted to posterior regions of 
the embryo and are expressed during later stages of embryogenesis (Krumlauf, 
1994).  Hoxa10 is located at the 5’end of the A cluster and is classified as an 
AbdB-like Hox gene because of its homology with the Drosophila AbdB gene.  
The Abd genes constitute a distinct subfamily of homeobox genes that exhibit 
posterior domains of expression including the genital imaginal disc in Drosophila 
and the developing genitourinary system in mammals (Dolle et al., 1991; Izpisua-
Belmonte et al., 1991).  Indeed, Hoxa10 is highly expressed in the developing 
genitourinary tract and adult female reproductive tract, suggesting its roles in 
reproductive events (Benson et al., 1996; Gendron et al., 1997; Hsieh-Li et al., 
1995).   
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Hoxa-10 null mice reveal FKBP52 as a critical mediator of implantation 
Definitive evidence for roles of various genes in implantation and/or 
decidualization has been demonstrated with an array of mouse gene knockout 
models.  Hoxa10 is strongly expressed in the mouse uterine stroma during the 
receptive phase (day 4), implantation (day 5) and decidualization (day 6) 
(Satokata et al., 1995).  Indeed, failure of decidualization in Hoxa10 null uteri 
leads to pregnancy failure (Benson et al., 1996).  Uterine stromal cells isolated 
from Hoxa10 null uteri show reduced proliferation in response to P4 contributing 
to decidualization defects, while epithelial cell proliferation remains normal in 
response to estrogen (Benson et al., 1996; Lim et al., 1999).  Several P4-
responsive genes are dysregulated in uterine stroma of Hoxa10 null uteri (Lim et 
al., 1999), suggesting that HOXA10 conveys P4 responsiveness by regulating 
gene expression as a transcription factor.  Furthermore, P4 is a strong inducer of 
Hoxa10 in mouse uterine stroma, inducing its expression within 4 h post-P4 
injection.  This upregulation is attenuated by the PR antagonist RU-486, 
suggesting a requirement for PR in Hoxa10 induction.   
Since the mechanism by which HOXA10 regulates uterine stromal cell 
proliferation and differentiation during uterine receptivity, implantation, and 
decidualization remained unexplored, we used proteomics approach to identify 
downstream targets of HOXA10 in the periimplantation uterus.  Specifically, we 
isolated stromal cells from wild-type and Hoxa10 null uteri, cultured them for 24 
h, and then analyzed them by 2D DIGE (two-dimensional difference gel 
electrophoresis).  More than 1000 proteins were resolved with isoelectric points 
17 
between pH 4 and 7 and molecular masses between 10 and 150 kDa. Among 
these, less than 4% (n=36) of the detected features displayed changes in 
abundance that were consistent across all three measurements, supported by 
Student’s t-test P values within the 99th percentile confidence interval (P<0.01, 
n=3) for the variance of mean changes.  Twenty-two of the identified proteins 
showed upregulation in Hoxa10 null stromal cells that primarily represented 
cytoskeletal, metabolic, and actin-related proteins (Table 1) (Daikoku et al., 
2005).  
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Table 1. Proteomic identification of up-regulated proteins in uterine stromal cells 
of Hoxa10 wild-type (+/+) and null (-/-) mice.  Fold abundance changes are 
reported, whereby a fold increase is calculated directly from the -/-: +/+ volume 
ratio, and a fold decrease = 1/volume ratio. 
 
Protein 
Name 
Fold Change
-/-: +/+ (n=3) 
t Test 
P Value (n=3) 
Functional 
Category 
 
Nonmuscle 
caldesmon 
 
2.65 
 
0.00017 
 
Actin-binding protein 
 
Fetuin A 
 
2.45 
 
1.80E-0.5 
Cytoskeletal protein, 
antiinflammation 
Coronin-like protein 
and ATP-dependent 
RNA helicase DDX19 
 
1.82 
 
1.10E-05 
 
Actin-related protein; 
RNA modification 
Plasminogen/activator 
inhibitor-1 
1.59 0.00018  
Inflammation 
Plasminogen/activator 
inhibitor-1 
1.44 3.70E-0.5  
Inflammation 
Transaldolase 1.51 1.50E-05 Metabolism 
Endoplasmic 
reticulum protein 
(ERp29) 
1.48 4.30E-0.5  
Chaperone 
Tropomyosin 1.43 0.00026 Actin-binding protein 
Gelsolin 1.40 1.70E-0.6 Actin-binding protein 
Aldehyde 
dehydrogenase 
1.37 0.00054  
Metabolism 
Lamin B1 1.35 0.0028 Glycoprotein, 
migration and 
proliferation 
Transaldolase 1.33 8.30E-05 Metabolism 
T complex protein 1 
α-subunit B 
1.32 0.0018  
Actin production 
HeteronuclearRNP K 1.30 0.0019 RNA modification 
Annexin A4 1.30 0.00028 Cell aggregation 
Annexin A1 1.29 0.004 Antiinflammation 
Protein disulfide 
isomerase A6 
1.27 0.018 Calcium-binding 
protein 
Protein disulfide 
isomerase A6 
1.26 0.00047 Calcium-binding 
protein 
Swiprosin 1 1.25 0.00061 Unknown 
Cytosolic nonspecific 
dipeptidase 
1.24 0.00026  
Protein modification 
Eukaryotic initiation 
factor 4A-1 
1.21 0.009  
RNA translation 
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The seven down-regulated proteins in Hoxa10 null stromal cells were 
mostly classified as metabolic with the exception of FK506-binding protein 4 
(FKBP52) that displayed a statistically significant decrease (P = 0.00021) (Table 
2) (Daikoku et al., 2005).   
 
Table 2. Proteomic identification of down-regulated proteins in uterine stromal 
cells of Hoxa10 wild-type (+/+) and null (-/-) mice.  Fold abundance changes are 
reported, whereby a fold increase is calculated directly from the -/-: +/+ volume 
ratio, and a fold decrease = 1/volume ratio. CoA, Coenzyme A. 
 
Protein 
Name 
Fold Change 
-/-: +/+ (n=3) 
t Test 
P Value (n=3) 
Functional 
Category 
Calreticulin (ERp60) -1.39 0.00083 Chaperone 
D-3-
phosphoglycerate 
dehydrogenase 
-1.34 1.90E-0.5 Metabolism 
D-3-
phosphoglycerate 
dehydrogenase 
-1.30 0.002 Metabolism 
Adenylate kinase 
isozyme 1 
-1.31 0.0014 Metabolism 
Succinly-CoA ligase -1.24 2.30E-0.5 Metabolism 
FKBP52 -1.22 0.00021 Chaperone 
Asparagine 
synthetase 
-1.20 0.0011 Metabolism 
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Peptide mass mapping and fragmentation spectra for FKBP52 are shown 
(Figure 2) (Daikoku et al., 2005). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mass spectrometry identifies FKBP52 protein as down-regulated in 
Hoxa10 null stromal cell cultures. (A) MALDI-TOF mass spectrum representing 
a peptide mass map of FKBP52. Ions labeled with an asterisk indicate peptide 
masses (M+H) that match predicted peptide masses for FKBP52 identified using 
the MASCOT search algorithm. MALDI-TOF/TOF tandem MS of the indicated 
ions is shown in panels B and C, with b-ion and y-ion cleavages that are 
consistent with the predicted amino acid sequence of the FKBP52-derived 
peptides depicted above and below the amino acid sequences, respectively. 
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Uterine Fkbp52 expression is cell specific and downregulated in Hoxa10 null 
mice  
 
We focused our attention to further characterize FKBP52 because of its 
known interaction with steroid receptors, in particular PR (Barent et al., 1998; 
Smith, 1993; Tai et al., 1986), its potential influence on receptor-hormone binding 
affinity (Riggs et al., 2003) and subcellular localization of receptors (Pratt et al., 
2004).  Immunostaining performed on sections of day 4 pseudopregnant mouse 
uteri show that FKBP52 protein is present in the stroma as well as the luminal 
and glandular epithelia in WT mouse uteri.  However, as expected, its levels are 
lower in Hoxa10 null uteri when compared to WT (Figure 3A & B).  Localization 
of Fkbp52 mRNA expression follows the pattern of immunolocalization (Figure 
3C).   
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FKBP52 is expressed in a spatiotemporal manner in the periimplantation uterus  
Fkbp52 is expressed in a unique temporal and cell-specific manner before 
implantation (days 1 and 4), at the time of implantation (day 5), and during the 
postimplantation (day 8) period (Figure 4A & B).  
Figure 3. Uterine expression of FKBP52 in day 4 pseudopregnant wild-type (+/+) 
and Hoxa10 null (-/-) mice. (A) Immunostaining of FKBP52 in uterine cross-
sections. Bar =  200 µm. (B) Western blot analysis of FKBP52. Actin serves as a 
control. (C) In situ hybridization of Fkbp52 expression in representative dark-field 
photomicrographs of longitudinal uterine sections from +/+ and -/- uteri. Bar = 400 
µm. le, luminal epithelium; ge, glandular epithelium; s, stroma; myo, myometrium.
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As mentioned, the uterus is under the influence of preovulatory estrogen 
on day 1 of pregnancy or pseudopregnancy with heightened cell proliferation in 
the epithelium.  In contrast, the day 4 uterus is exposed to rising levels of P4 from 
the newly formed corpora lutea and fortified with a small amount of estrogen that 
results in epithelial cell differentiation with stromal cell proliferation. We observed 
that Fkbp52 mRNA is detected mostly in the luminal epithelium on day 1 of 
Figure 4. Uterine expression of FKBP52 in wild-type mouse uteri during early 
pregnancy. (A) In situ hybridization of Fkbp52. Hybridization signals in 
representative dark-field photomicrographs of longitudinal uterine sections on 
day 1 and day 4 and cross-sections on days 5 and 8 are shown. Bar = 400 
µm. le, luminal epithelium; ge, glandular epithelium; s, stroma; myo, 
myometrium; m, mesometrial pole; am, anti-mesometrial pole; Dc, decidua. 
Arrows indicate location of embryo. (B) Western blotting of FKBP52 protein. 
Actin serves as a loading control. 
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pregnancy when the uterus is primarily under the influence of estrogen.  On day 
4, the expression expands into the stroma with its persistent expression in the 
luminal and glandular epithelia, suggesting that ovarian steroids coordinate the 
differential expression of Fkbp52.  Because P4 effects are correlated with 
epithelial cell differentiation and stromal cell proliferation on day 4, it is speculated 
that FKBP52 in the epithelium and stroma directs these events in the context of 
cell types. This is consistent with a similar expression pattern of nuclear PR in the 
uterus on this day (Tan et al., 1999). 
 On the morning of day 5 of pregnancy, the attachment between the 
luminal epithelium and blastocyst trophectoderm is in the early stages marked by 
continued stromal cell proliferation and endometrial vascular permeability solely 
at the site of the blastocyst (Dey et al., 2004).  On this day, expression of Fkbp52 
is uniquely displayed in the stroma surrounding the implanting blastocyst (Figure 
4A).  The localization of Fkbp52 surrounding the embryo on day 5 suggests that 
the process of implantation has an impact on uterine expression of this 
immunophilin.  On day 8 of pregnancy, the implantation process is well advanced 
with maximal stromal cell decidualization (Dey et al., 2004).  In mice, the 
proliferating and differentiating stromal cells surrounding the implanting 
blastocyst begin to form the primary decidual zone (PDZ) on the afternoon of day 
5.  The PDZ is avascular and densely packed with decidual cells.  By day 6, the 
PDZ is well formed and a secondary decidual zone (SDZ) is formed around the 
PDZ.  At this time, cell proliferation ceases in the PDZ, but still continues in the 
SDZ (Dey et al., 2004), and a thin layer of undifferentiated stromal cells 
25 
establishes a boundary between the myometrium and the SDZ.  The PDZ 
progressively degenerates through day 8; at this point, placental and embryonic 
growth gradually replaces the SDZ, which is reduced to a thin layer of cells called 
the decidua capsularis.  The mesometrial decidual cells eventually form the 
decidua basalis (Dey et al., 2004).  On day 8, expression of Fkbp52 dramatically 
changes, lying in peripheral decidualizing cells more specifically at the 
mesometrial SDZ and the undifferentiated stroma situated between the deciduum 
and myometrium.  Interestingly, Fkbp52 is also evident in the growing embryo on 
this day (Figure 4A).  Western blotting confirms translation of Fkbp52 mRNA 
during these days of pregnancy (Figure 4B).  Collectively, these results suggest 
that ovarian steroid hormones and implantation events differentially affect uterine 
Fkbp52 expression. 
 
Progesterone and estrogen differentially regulate Fkbp52 expression in the 
uterus 
 
Our results showing differential expression of Fkbp52 on days 1 and 4 of 
pregnancy suggested that this gene is regulated in the uterus by ovarian steroids 
in a cell-specific manner.  Indeed, in situ hybridization was performed to 
determine the uterine cell-specific expression of Fkbp52 in response to the 
ovarian steroid hormones P4 and/or estrogen (Figure 5).   
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We observed that Fkbp52 expression is low in uteri of ovariectomized 
mice treated with oil (vehicle control) and that this expression is primarily 
restricted to the luminal and glandular epithelia with low to undetectable 
Figure 5. Uterine Fkbp52 expression in ovariectomized mice after various steroid 
hormone treatments. (A) In situ localization of Fkbp52 in wild-type uteri is shown 
in representative dark-field photomicrographs of longitudinal uterine sections. (B) 
In situ hybridization of Fkbp52 in Pgr–/– uteri. Ovariectomized mice were treated 
with oil (control), E2 (100 ng), P4 (2 mg), or E2+P4 and killed 12 h following 
treatment. Bar = 200 µm. le, luminal epithelium; ge, glandular epithelium; s, 
stroma; myo, myometrium. (C) RT-PCR detection of Fkbp52 in wild-type uteri. 
Ovariectomized mice were treated with P4 and/or E2 for the indicated times. (D) 
RT-PCR detection of Fkbp52 in Pgr–/– uteri. rPL7 is a housekeeping gene. The 
data presented as fold induction are relative to oil treatment and are mean ± SE. 
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expression in the stroma. An injection of estradiol-17β (E2, 100 ng/0.1 ml/mouse) 
upregulated Fkbp52 expression levels by 12 h with the pattern remaining 
unaltered. In contrast, an injection of P4 (2 mg/0.1 ml/mouse) showed a 
prominent shift in Fkbp52 expression from the luminal epithelium to the stromal 
compartment at 12 h and expression was downregulated by 24 h (Figure 5A). A 
combined injection of E2 and P4 showed an expression pattern similar to that of 
P4 alone but at somewhat lower levels (Figure 5A). Interestingly, P4 treatment 
markedly downregulated E2-induced epithelial Fkbp52 expression. Comparative 
RT-PCR analysis of total RNA isolated from uteri harvested from similarly treated 
mice confirmed our in situ hybridization results, showing an increase in Fkbp52 
expression in E2, P4, and E2 + P4 treatment at 12 h with a return to basal levels at 
24 h (Figure 5C).  
We next used mice lacking nuclear PR to further define the mechanism of 
steroidal regulation of Fkbp52. The induction of stromal Fkbp52 expression that 
we observed in P4-treated wild-type mice was virtually abolished in Pgr null mice 
(Figure 5B). However, the E2 response remained intact, showing a similar 
increase in Fkbp52 expression in the luminal epithelium as was observed in WT 
uteri (Figure 5B). In situ hybridization results were further confirmed by 
comparative RT-PCR analysis of total RNA isolated from uteri harvested from 
similarly treated Pgr null mice, showing an increase in Fkbp52 expression with E2 
treatment, but no such increase in ovariectomized Pgr null mice treated with P4 
(Figure 5D). Collectively, these results suggest that steroid hormones regulate 
Fkbp52 expression differentially and in a cell-specific manner. This observation of 
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differential regulation of FKBP52 by estrogen and P4 points to a role for FKBP52 
in epithelial-stromal cross-talk to mediate full complement of uterine functions in 
response to ovarian steroid hormones. 
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CHAPTER II 
 
COCHAPERONE IMMUNOPHILIN FKBP52 IS CRITICAL TO UTERINE 
RECEPTIVITY AND IMPLANTATION 
 
Abstract 
Embryo implantation in the uterus is a critical step in mammalian 
reproduction, requiring preparation of the uterus receptive to blastocyst 
implantation. Uterine receptivity lasts for a limited period, and it is during this 
period that blastocysts normally implant. Ovarian steroid hormones estrogen and 
P4 are the primary regulators of this process. FKBP52, an immunophilin, serves 
as a cochaperone for steroid hormone nuclear receptors to govern appropriate 
hormone action in target tissues. Here we show a critical role for FKBP52 in 
mouse implantation. This immunophilin has unique spatiotemporal expression in 
the uterus during implantation, and females missing the Fkbp52 gene have 
complete implantation failure due to the lack of attainment of uterine receptivity. 
The overlapping uterine expression of FKBP52 with nuclear PR in wild-type mice 
together with reduced P4 binding to PR, attenuated PR transcriptional activity and 
downregulation of several P4-regulated genes in uteri of Fkbp52 null mice, 
establishes this cochaperone as a critical regulator of uterine P4 function. 
Interestingly, ovulation, another P4-mediated event, remains normal in Fkbp52 
null animals. Collectively, the present investigation provides evidence for an in 
vivo role for this cochaperone in regulating tissue-specific hormone action and its 
critical role in uterine receptivity for implantation. 
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Introduction 
 Immunophilins are aptly named due to their ability to bind and mediate 
actions of certain immunosuppressive drugs. Immunophilins are grouped into two 
protein families: the FK506-binding proteins (FKBPs) and the cyclosporin A 
binding proteins termed cyclophilins (CyPs).  FKBP and CyP typically exhibit 
peptidylprolyl cis-trans isomerase (PPIase) activity, and this PPIase domain also 
forms the drug-binding site (Fanghanel and Fischer, 2004).  Some members of 
the FKBP and CyP families contain a tetratricopeptide repeat (TPR) domain that 
targets binding to the highly conserved C-terminal end of heat shock protein 90 
(Hsp90), and thus participate as cochaperones with Hsp90 in its substrate 
interactions.  
FKBP52 and its related immunophilins FKBP51 and CyP40 were initially 
characterized as Hsp90-binding proteins because of these conserved TPR 
domains (Pratt and Toft, 1997).  Hsp90 is bound with high affinity to the PR 
complex in an ATP-bound state.  ATP binding changes the conformation of the 
protein and therefore, the ATP turnover rate determines the amount of time 
Hsp90 remains bound to its target protein.  This turnover rate is regulated by 
Hsp90’s association with cochaperones, one being p23.  This small, acidic co-
chaperone is known to inhibit the ATPase activity of human Hsp90, and this 
inhibition is shown to be more robust in the presence of FKBP52 (McLaughlin et 
al., 2002); however, while various roles for p23 in these complexes have been 
proposed, its precise function and the molecular mechanism by which p23 
mediates its functions are unknown.  
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The pathway for assembly of steroid receptor/chaperone complexes is 
complex, involving a variety of Hsps and cochaperones.  For PR specifically, it is 
thought that this steroid hormone nuclear receptor first binds to Hsp40 and 
Hsp70 in the cytoplasm of the cell.  This is followed by the binding of Hop-Hsp90 
to the bound Hsp70 (Hernandez et al., 2002).  Hsp70 and Hop then dissociate 
from this intermediate PR complex, while p23 is recruited to receptor-bound 
Hsp90.  The PR complex with Hsp90 and p23 bound then recruits one of the 
cochaperone immunophilins (FKBP51, FKBP52, CyP40, or protein phosphatase 
5 (PP5)) to an Hsp90 binding site.  For PR, if this mature complex is bound to 
FKBP52, then it is capable of optimally binding P4 ligand.  The mature complex 
containing Hsp90 must be maintained so that the receptor can bind P4 with high 
affinity and efficiency.  Recent reports indicate that each steroid hormone nuclear 
receptor (GR, ER, and PR)-Hsp90 complex displays preferential binding with 
specific immunophilins (Barent et al., 1998).   
FKBP52 and FKBP51 share a common binding site on Hsp90 and 
therefore compete for assembly with steroid receptor complexes (Riggs et al., 
2003).  The PR heterocomplex, however, preferentially assembles with FKBP51 
despite its lower concentration in the cell (20 nM) when compared to FKBP52 
(100 nM) (Schiene-Fischer and Yu, 2001).  FKBP52 elevates the hormone 
binding affinity of PR in an Hsp90- and PPIase-dependent manner, while 
FKBP51 antagonizes the actions of FKBP52 and reduces PR binding affinity for 
ligand, thereby reducing secondary responses to hormones (Riggs et al., 2003).  
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It is surprising that functional differences exist between these two immunophilins, 
given the 70% homology in their amino acid sequences (Nair et al., 1997).   
It has been suggested that while FKBP52 is necessary for potentiating PR 
activity through optimal ligand binding, basal PR activity can exist without 
FKBP52 presence, albeit not as efficiently.  The mechanism by which FKBP52 
potentiates receptor hormone-binding ability is still unclear.  Point mutation of the 
FKBP52 TPR domain demonstrates that an association of FKBP52 with Hsp90 is 
critical (Riggs et al., 2003), suggesting that FKBP52 is obligatorily recruited to the 
receptor complex by Hsp90.  In addition, point mutation of the FKBP52 PPIase 
domain or addition of the PPIase inhibitor, FK506, blocks receptor potentiation, 
which perhaps reflects a direct interaction between the PPIase domain and 
receptor sites.  FKBP52 and FKBP51 have similar PPIase activity towards small 
peptide substrates (Pirkl and Buchner, 2001), and their respective PPIase 
domains share 80% sequence similarity; yet, FKBP51 fails to potentiate receptor 
activity.  Chimeric constructs in which the PPIase domain has been exchanged 
confirms that the FKBP52 PPIase domain is unique in its ability to stimulate 
receptor activity (Riggs et al., 2003).  However, the receptor site(s) putatively 
targeted by the FKBP52 PPIase domain have not been identified although it is 
known that they localize to the LBD (Riggs et al., 2003).  Mapping of specific 
amino acid differences within the PPIase domains of FKBP52 and FKBP51 
should provide further insight into mechanism(s) of receptor potentiation or 
inhibition.  
33 
There is additional evidence that FKBP52, through a dynein-binding ability 
lacking in FKBP51, can enhance nuclear translocation of hormone-bound GR 
(Davies et al., 2002; Pratt et al., 2004; Wochnik et al., 2005).  This role for 
FKBP52 is based on evidence that FKBP52 binds both a nuclear localization 
signal (NLS) and dynein (Czar et al., 1995; Galigniana et al., 2004; Silverstein et 
al., 1999), and on in vitro studies demonstrating that FKBP52 facilitates the 
nuclear transport of both GR and p53 (Galigniana et al., 2004; Galigniana et al., 
2001; Wochnik et al., 2005).  Evidence suggests that FKBP52 binds dynein 
directly through its PPIase domain (Silverstein et al., 1999).  It is debated 
whether FKBP52 facilitates a similar translocation of PR (Silverstein et al., 1999), 
and it is not yet clear what contribution dynein associations play relative to direct 
FKBP-mediated effects on hormone binding, especially with PR and other 
receptors that prior to hormone binding have a more predominant nuclear 
localization than GR. Steroid hormone binding prevents reinitiation of the 
heterocomplex assembly cycle in the cytoplasm, and while it is known that 
hormone binding is followed by heterocomplex dissociation, it is not known 
whether the complex dissociates during nuclear transport or within the nucleus.  
Once in the nucleus, however, as described earlier, nuclear PR forms 
homodimers to act as a transcription factor to either activate gene transcription 
by binding to its cognate DNA elements or to inhibit transcription through 
interaction with other transcription factors.   
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The purpose of this next study, therefore, was to examine a physiological 
role for FKBP52 and FKBP51 in an in vivo context, since roles for these 
cochaperones had not been examined with respect to P4-dependent processes.   
 
Methods 
 
Generation of Fkbp52 null mice   
ES cells isolated from 129SvJ mouse were cultured in Knockout DMEM 
(Invitrogen, Carlsbad, CA) supplemented with 10% FBS, penicillin/streptomycin, 
essential amino acids, ESGRO (103 U/ml; Chemicon, Temecula, CA) with 
irradiated embryonic fibroblast feeder cells. ES cells were electroporated at 0.2 
kV, 950 µF (Gene Pulser II; Bio-Rad, Hercules, CA) with linearized targeting 
vectors and selected with G418 (300 µg/ml). DNA from G418-resistant clones 
was isolated for Southern blot analysis. A DNA probe was used to distinguish 
EcoRI restriction fragments from wild-type (17 kb) and mutant (9 kb) alleles. 
Appropriate homologous recombination in ES cell clones was confirmed by PCR 
using primers complementary to sequences within the neomycin cassette and to 
3' Fkbp52 sequences downstream from the recombination site. ES cell clones 
containing a mutant Fkbp52 allele were injected into C57BL6/129 blastocysts and 
implanted into pseudopregnant 129SvJ females. Chimeric offspring were 
identified by coat patterns and mated to C57BL6/129 mice to obtain germline 
transmission of the mutant allele.  These mice were created by David F. Smith 
(Mayo Clinic, Scottsdale, AZ) and are currently maintained in our animal facility 
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at Vanderbilt University (Nashville, TN).  All mice were housed and used in the 
current investigation in accordance with the National Institutes of Health and 
institutional guidelines on the care and use of laboratory animals. 
 
Mouse genotyping  
To obtain genomic DNA, tail pieces (5–8 mm) collected from weaned mice 
were placed in 200 µl DirectPCR Lysis Reagent (Viagen Biotech Inc., Los 
Angeles, CA) containing freshly prepared 0.2-0.4 mg/ml Proteinase K (Sigma, St. 
Louis, MO).  Tails were placed in 55oC water bath for > 6 h.  Lysates were then 
incubated at 85oC for 45 min, spun down quickly for 10 sec, and stored at 4oC 
until use.  Genotypes were determined by PCR using specific primers: neoF2, 5’-
TCT ATC GCC TTC TTG ACG-3’; ex2F, 5’-AGA GAG GGT ACA GC-3’; ex3R, 
5’-TAC AAG TGT GGC GTT GGG-3’; ex10R, 5’-ATG CAA CAG CGG TGT ACC 
C-3’.  These are specific for the wild-type (1 kb product) or mutant (700 bp 
product) alleles.  Cycle conditions are the following: 1 cycle of 95oC for 5 min, 
followed by 40 cycles of 95oC for 30 sec, 55oC for 30 sec, 68oC for 2.5 min, 
followed by 68oC for 10 min.  Master mix contained 10x LA Taq PCR buffer, 2.5 
mM dNTP mixture, 10 µM primer mix, and LA Taq polymerase (Takara Bio Inc, 
Shiga, Japan).  Amplified fragments were separated by electrophoresis on 2% 
agarose gels and visualized by ethidium bromide staining. 
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Ovulation, fertilization, implantation, and blastocyst transfer  
To examine ovulation and fertilization, wild-type or Fkbp52-/- mice were 
bred with fertile males. The morning of finding a vaginal plug was designated day 
1 of pregnancy. Mice were killed on day 2 of pregnancy and oviducts were 
flushed with Whitten’s medium to recover eggs and embryos. Egg and embryo 
morphology was examined under a dissecting microscope.  Implantation sites on 
days 5 and 6 of pregnancy were visualized by an intravenous injection (0.1 ml per 
mouse) of a Chicago Blue B dye solution (1% solution in saline) and the number 
of implantation sites, as demarcated by distinct blue bands, was recorded. For 
blastocyst transfer, pseudopregnant recipients were generated by mating females 
with vasectomized males. Day 4 wild-type blastocysts were transferred into day 4 
uteri of wild-type, heterozygous or Fkbp52-/- pseudopregnant recipients, and 
implantation sites were recorded 24 h later (day 5) by the blue dye method. All 
mice used were between 2 and 4 months of age.  
 
Comparative RT-PCR and southern hybridization  
Total RNA was extracted from mouse uteri using Trizol according to the 
manufacturer’s instruction. Reverse transcription with oligo(dT) priming was 
performed to generate cDNAs from 4 µg total RNA using Superscript II following 
the instruction provided by the manufacturer. DNA amplification was carried out 
with Taq DNA polymerase (Invitrogen, San Diego, CA) using the following 
primers: Fkbp52 (437 bp), 5'-AGT GTG GGG AAG GAG AGG TT-3' and 5'-GCT 
CTT GCC AGG TCA AAG TC-3'; Pgr (461 bp), 5'-GCC ATC ACT TCC TGG TGT 
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CT -3' and 5'-GCA ATG GGA GAG TCT TGC TC-3'; Fkbp51 (402 bp), 5’-AAG 
GTG TTG GCA GTC AAT CC-3’ and 5’-GGT GGT CAT TTG GGA AGC TA-3’; β-
actin (246 bp),  5’-CTC TTT GAT GTC ACG CAC GAT TTC-3’ and 5’-GTG GGC 
CGC TCT AGG CAC CAA-3’. PCR conditions were 95oC for 5 min and then 23 
cycles of 94oC for 30 sec, 60oC for 30 sec, and 72oC for 45 sec, followed by 
incubation at 72oC for 10 min. Amplified fragments were separated by 
electrophoresis on 2% agarose gels and visualized by ethidium bromide staining. 
The intensity of each band was measured by Scion Image (Scion Corp., 
Frederick, MD), and intensities of Fkbp52, Pgr, and Fkbp51 were corrected by 
the intensity of β-actin. Nested primers used to make hybridization probes were 
as follows: Fkbp52, 5’-CAC GCT GAG CTG AGG TAT GA-3’; Pgr, 5’-GTC TCT 
TTG GGC CAG AGC TT-3’; β-actin 5’-CCA CGG GCA TTG TGA TGG AC-3’.  
Southern blots were prehybridized and hybridized at high stringency.  
Hybridization was carried out for ~16 h at 37oC in 3x SET (1x SET=150 mM 
NaCl, 5 mM EDTA and 10mM Tris-HCl, pH 8.0), 20 mM phosphate buffer (pH 
7.2), 250 µg/ml tRNA, 10% dextran sulfate and ~2 x 106 counts/min 32P-labeled 
antisense RNA probe/ml of the hybridization buffer.  After hybridization, the blots 
were washed once in 1x SSC, 0.1% SDS for 1 h at 37oC, followed by a second 
wash in 0.3x SSC, 0.1% SDS for 1 h at 37oC.  Hybrids were detected by 
autoradiography.   
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P4 binding assay   
Ovariectomized wild-type or Fkbp52-/- mice were injected s.c with 
estradiol-17β (1 µg/mouse) or vehicle (sesame oil) for 14 days to increase PR 
levels. Aliquots of wild-type or Fkbp52-/- uterine cytosol (200 µg of total protein) 
were incubated overnight at 4°C in the presence of indicated concentrations of 
[3H]P4 (NEN, specific activity = 102.1 Ci/mmol; 1 Ci = 37 GBq), a 100-fold molar 
excess of cortisol plus or minus a 100-fold molar excess of unlabeled P4. 
Unbound ligand was removed by incubation with dextran-coated charcoal, and 
bound radioactivity in the supernatant was measured by liquid scintillation 
counting. 
 
Transfection and PR transcription activity assay   
Cells (8 x 104 per well) were cotransfected with 20 ng of pCMV-
galactosidase plasmid (Clontech), 0.3 µg of pCR3.1-hPRB expression plasmid 
(kindly provided by N. Weigel, Baylor College of Medicine, Houston, TX), 0.3 µg 
of pMMTV-luc reporter plasmid (provided by J. Scammell, University of South 
Alabama, Mobile, AL), and 0.3 µg of pCI-neo vector (Promega) lacking or 
containing human Fkbp51 or Fkbp52 cDNA. Cells were incubated overnight with 
P4 as indicated. After transfection, 10 nM DHT was added, and cells were 
incubated an additional 24 h. Treated cells were washed three times with PBS 
and lysed with 100 µl of M-PER reagent. For luciferase (Luciferase Assay 
System; Promega) and β-galactosidase (Gal-Screen) assays, 30 µl and 20 µl, 
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respectively, of cell lysate were added to substrate mixtures and assayed 
according to suppliers’ instructions.  
 
In situ hybridization   
In brief, frozen sections (12 µm) were mounted onto poly-L-lysine-coated 
slides and fixed in cold 4% paraformaldehyde in PBS. After prehybridization, 
sections were hybridized at 45°C for 4 h in 50% formamide hybridization buffer 
containing the 35S-labeled antisense or sense cRNA probes. Ribonuclease A-
resistant hybrids were detected by autoradiography. Sections were poststained 
with eosin and hematoxylin. Sections hybridized with sense probes did not exhibit 
any positive signals and served as negative controls. 
 
Northern hybridization  
Total RNA (6 µg) was denatured, separated by formaldehyde-agarose gel 
electrophoresis and transferred onto nylon membranes.  Cross-linked blots were 
prehybridized, hybridized, and washed at conditions for high stringency.  Briefly, 
hybridization was carried out at ~16 h at 68oC in 3x SET (1x SET=150 mM NaCl, 
5 mM EDTA and 10mM Tris-HCl, pH 8.0), 20 mM phosphate buffer (pH 7.2), 250 
µg/ml tRNA, 10% dextran sulfate and ~2 x 106 counts/min 32P-labeled antisense 
RNA probe/ml of the hybridization buffer.  After hybridization, the blots were 
washed once in 1x SSC, 0.1% SDS for 1 h at 68oC, followed by a second wash 
in 0.3x SSC, 0.1% SDS for 1 h at 68oC.  Hybrids were detected by 
autoradiography.   
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Isolation and culture of embryonic fibroblasts   
Day 13 embryos were isolated and genotyped by PCR as described. The 
head, limbs, and liver were excluded from each embryo, and remaining tissues 
were minced and digested with 0.25% trypsin at 37°C for 15 min, and plated in 
60-mm plastic dishes in DMEM supplemented with 10% FBS plus essential 
amino acids and penicillin/streptomycin. Fibroblasts were immortalized by the 
3T3 protocol of Todaro and Green (Todaro and Green, 1963).  These cultures 
were performed in the laboratory of David F. Smith (Mayo Clinic, Scottsdale, AZ).   
 
Histology and Immunostaining of Ki67 
Frozen (10 µm) or formalin-fixed paraffin embedded uterine sections (5 
µm) were subjected to hematoxylin and eosin staining or immunostaining by 
using a Ki67 antigen staining kit according to the manufacturer’s instructions, 
respectively (Novacastra, Newcastle, U.K.)  Nuclear brown color indicates 
positive Ki67 staining. 
 
Results 
 
Ovulation is normal in C57BL6/129 Fkbp52 null females  
To delineate whether FKBP51 or FKBP52 plays a critical role in ovarian 
and uterine functions, we generated mice with targeted deletion of either Fkbp51 
or Fkbp52 genes. We found that, although Fkbp51 deficient mice show no overt 
reproductive failures (unpublished observations), both males and females lacking 
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Fkbp52 are infertile (Cheung-Flynn et al., 2005; Hong et al., 2007), indicating the 
importance of this immunophilin in reproduction. The infertility status of Fkbp52-/- 
females is shown (Table 3).   
 
Table 3. Fertility status of C57BL6/129 Fkbp52 null (-/-) female mice. Fkbp52-/- 
females cohabitated with wild-type (+/+) fertile males failed to produce any 
offspring, while the average litter sizes from +/+ and heterozygous (+/-) females 
were comparable (mean ± SD). 
 
Genotypes 
(males x females) 
 
 
No. of breeders
 
 
No. of litters 
 
 
Average litter size 
+/+  x  +/+ 28 81 6.9 ± 3.0 
+/-  x  +/- 63 195 6.7 ± 3.0 
+/+  x  -/- 53 0 0 
 
 
Whereas male infertility is due to compromised androgen receptor function and 
decreased sperm fertilizing capacity (Cheung-Flynn et al., 2005; Hong et al., 
2007), the site and cause of female infertility in Fkbp52 null females remained 
unexplored. 
Because Pgr null mice show ovulation failure and uterine refractoriness to 
implantation (Lydon et al., 1995; Mulac-Jericevic et al., 2003), and because 
FKBP52 associates with PR-Hsp90 complexes (Barent et al., 1998), we first 
examined whether ovulation is normal in Fkbp52-/- females. Because Fkbp52-/- 
males are infertile, normally cyclic or gonadotropin-stimulated Fkbp52-/- females 
were mated with fertile wild-type males. The number of normally ovulated or 
superovulated eggs in these mutant females is comparable to that of wild-type 
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females (Figure 6A); however, both in vivo and in vitro fertilization rates of eggs 
arising from mutant females are compromised (Figure 6A).  
 
 
 
 
 
 
 
 
 
 
Figure 6. Female reproductive events in C57BL6/129 Fkbp52-/- mice. (A) 
Ovulation and fertilization were examined on day 2 of pregnancy. Numbers within 
the bars indicate number of fertilized eggs/total number of ovulated eggs. Normal 
and superovulation rates are not significantly different between +/+ and -/- mice 
(unpaired t-test); normal or in vitro fertilization rates are significantly different 
between +/+ and -/- mice ( 2 analysis; *P = 0.01). (B) RT-PCR of Fkbp52 and Pgr 
expression in preimplantation embryos. (C) Representative photographs of +/+ 
uteri with implantation sites and Fkbp52-/- uteri without on day 5. Arrowheads and 
arrows indicate sites of ovary and implantation, respectively. (D) Representative 
photomicrograph of blastocysts recovered from Fkbp52-/- mice on day 5. Bar = 50 
µm.) 
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To determine whether oocyte FKBP52 contributes to the reduced 
fertilization rates, we examined the expression of Fkbp52 and Pgr in 
preimplantation wild-type embryos from one-cell through blastocyst stages by 
RT-PCR. We found that, although embryos at all stages of development express 
Fkbp52, Pgr is expressed only at the blastocyst stage (Figure 6B); our 
observation of Pgr expression specifically in blastocysts and not in the other 
stages of preimplantation embryos is consistent with a previous report (Hou and 
Gorski, 1993). These results suggest that Fkbp52 is maternally derived in the 
oocyte and may have a role in fertilization and preimplantation development 
independent of PR. Alternatively, oocyte maturation due to follicular deficiency 
arising from compromised PR function in the absence of FKBP52 may contribute 
to the reduced fertilization rate.  Indeed, there is evidence that compromised PR 
function impairs the expansion of cumulus-oocyte complexes (Shimada et al., 
2004). Further investigation is needed to address this question. 
It is to be noted, however, that recovery of blastocysts from Fkbp52-/- uteri 
on day 4 of pregnancy suggests that FKBP52 is not an absolute requirement for 
fertilization or preimplantation embryo development. Collectively, these results 
imply that complete infertility observed in Fkbp52-/- females is not due to failure in 
ovulation as in Pgr-/- mice, or total absence of fertilization, but is the result of 
defective implantation and/or pregnancy failure following implantation.  
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Fkbp52-/- mice show implantation failure 
To determine whether implantation occurs normally in Fkbp52-/- females, 
we mated wild-type, heterozygous and null females with fertile males of the same 
strain and examined implantation on day 5 of pregnancy by the described blue 
dye method. We observed that, although wild-type and heterozygous females 
had an expected number of implantation sites when examined on day 5 of 
pregnancy, none of the mutant females showed any sign of implantation (Figure 
6C & D; Table 4). It is possible that blastocyst implantation is delayed in Fkbp52-
/- mice like in cPLA2 -/- or Lpa3-/- mice (Song et al., 2002; Ye et al., 2005); 
however, no signs of implantation were evident even on day 6 of pregnancy 
(Table 4). In fact, a small number of unimplanted blastocysts were recovered 
from mutant females on this day of pregnancy (Table 4). 
 
Table 4. C57BL6/129 Fkbp52 null (-/-) female mice show implantation failure. 
+/+, +/-, and -/- females were mated with +/+ fertile males and the number of 
implantation sites (IS) was examined on days 5 and 6 of pregnancy by the blue 
dye method.  Uteri without IS were flushed with saline to recover any 
unimplanted embryos.  The results of +/+ and +/- mice were not significantly 
different and are presented as a pool (mean ± SD). 
 
Day of  
pregnancy 
 
Genotypes 
 
No. 
of mice 
 
No. of mice 
with IS (%) 
 
No. of IS 
No. of 
embryos 
recovered 
5 +/+ / +/- 12 9 (75) 6.5 ± 2.0 0a 
5 -/- 9 0 0 37b 
6 +/+ / +/- 14 10 (71) 7.9 ± 2.0 2c 
6 -/- 5 0 0 5d 
a 3 mice without IS yielded no embryos. 
b15 embryos were at the blastocyst stage, and the remaining 22 were 
degenerating embryos and thus, their fertilization status could not be 
ascertained. 
c 2 degenerating embryos were recovered from 1 mouse. 
d 5 blastocysts were recovered from 1 mouse.  
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Compromised fertilization in Fkbp52-/- mice could explain the small number 
of recovered blastocysts in mutant mice. Therefore, we used blastocyst transfer 
experiments to confirm that FKBP52 is critical to uterine receptivity for 
implantation. Day 4 wild-type blastocysts were transferred to wild-type, 
heterozygous, or homozygous mutant day 4 pseudopregnant recipients. Similar 
to the results of natural mating, none of the transferred wild-type blastocysts 
showed implantation in any of the mutant recipients when examined 24 h post-
transfer, whereas wild-type or heterozygous recipients showed an expected 
number of implantation sites. Again, a small number of blastocysts were 
recovered from mutant uteri (Table 5). Reciprocal embryo transfers with 
homozygous mutant embryos could not be performed because Fkbp52-/- males 
are infertile (Cheung-Flynn et al., 2005; Hong et al., 2007).  
 
Table 5. Wild-type blastocysts fail to implant in C57BL6/129 Fkbp52 null (-/-) 
recipients. Day 4 wild-type (+/+) blastocysts were transferred into uteri of +/+, +/-, 
or -/- recipients on day 4 of pseudopregnancy.  Recipients were examined for 
implantation sites (IS) on day 5 by the blue dye method.  Uteri without IS were 
flushed with saline to recover any unimplanted blastocysts.  The results of +/+ 
and +/- mice were not significantly different and are presented as a pool (mean ± 
SD).  
 
Genotype 
 
Blastocyst 
 
Recipient 
 
 
No. of 
blastocysts 
transferred 
 
 
 
No. of 
recipients
 
 
No. of 
mice with 
IS (%) 
 
 
 
No. of IS 
(%) 
 
 
No. of 
blastocysts 
recovered 
+/+ +/+  /  +/- 178 10 8 (80) 74 (41) 2a 
+/+ -/- 79 4 0 (0) 0 14b 
a  2 mice without IS yielded 1 blastocyst each. 
b  14 blastocysts were recovered from 3 recipients.   
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Collectively, these results show that, whereas P4-mediated ovulation is 
normal in Fkbp52-/- mice, the mutant uterus is completely nonreceptive to 
blastocyst implantation, implying an essential role for this immunophilin 
specifically for governing uterine receptivity. Our next objective was to determine 
whether these phenotypes resulting from Fkbp52 deficiency are caused by 
impaired P4 function in the uterus.  
 
FKBP52 and PR show overlapping uterine expression during implantation  
We speculated that, if FKBP52 functions as a cochaperone to PR in vivo, 
cell-specific expression of these two genes must overlap. In situ hybridization 
results show that on day 4 of pregnancy, Fkbp52 and Pgr expression overlaps in 
the stroma. However, Fkbp52 is also expressed in the luminal and glandular 
epithelium. Both Fkbp52 and Pgr become more localized in stromal cells 
surrounding the blastocyst on day 5 after initiation of attachment (Figure 7A).  
This mRNA expression translates to their protein expression (Figure 7B). 
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The overlapping expression pattern of FKBP52 and PR coincides with an 
increased stromal cell proliferation on day 4 and more intensely localized stromal 
cell proliferation at the implantation site on day 5.  Uterine Fkbp51, although 
significantly lower compared to Fkbp52, is also expressed on days 4 and 5 
(Figure 8A). The lower expression of Fkbp51 on days 4 and 5 implies a limited 
role for this immunophilin during implantation and is consistent with normal 
fertility of Fkbp51-/- female mice.   
 
 
 
 
 
Figure 7. Uterine expression of FKBP52 and PR on days 4 and 5 of pregnancy. 
(A) In situ hybridization of Fkbp52 and Pgr in wild-type uteri on days 4 and 5 of 
pregnancy. (B) Immunostaining showing FKBP52 and PR protein expression in 
serial sections on days 4 and 5 of pregnancy.  Bar = 400 µm. Arrows indicate 
location of blastocysts. le, luminal epithelium; ge, glandular epithelium; s, 
stroma. 
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However, we wanted to determine whether an interaction between FKBP51 and 
FKBP52 modulates PR transcriptional activity. Using mouse embryonic 
fibroblasts (MEFs) in cellular assays, we found that FKBP51 is antagonistic to 
FKBP52 in modulating PR transcriptional activity (Figure 9).  
 
 
Figure 8. Uterine expression of Fkbp51 in C57BL6/129 wild-type versus Fkbp52-/- 
uteri. (A) In situ hybridization of Fkbp51 in wild-type uteri on days 4 and 5 of 
pregnancy. Arrow indicates blastocyst. Bar = 400 µm. (B) RT-PCR of Fkbp51 
expression in +/+, +/-, and -/- uteri on day 4 of pregnancy.  Data are presented as 
fold changes (mean ± SEM). Fold changes are not significantly different between 
+/+, +/-, or -/- mice (unpaired t-test). 
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Because FKBP51 attenuates PR responses due to FKBP52, we next 
wanted to determine whether Fkbp51 is overexpressed in Fkbp52-/- uteri 
contributing to the observed reproductive defects.  To address this, we used 
comparative RT-PCR experiments and found that Fkbp51 expression is not 
exacerbated in mutant uteri on day 4 of pregnancy (Figure 8B). Collectively, 
these results indicate that Fkbp52 null phenotypes are specific to Fkbp52 
deficiency and not due to overexpression of Fkbp51. 
Given these results, we then compared Pgr expression in Fkbp52 null uteri 
with wild-type uteri.  In situ hybridization results show that Pgr is expressed in 
both the stroma and epithelium of null uteri similar to that in wild-type uteri 
Figure 9. Differential modulation of PR transactivation by FKBP52 and FKBP51. 
Fibroblast cell lines prepared from wild-type (WT), Fkbp52-/-, or Fkbp51-/- mouse 
embryos were cotransfected with four plasmids. Cells were treated with or without 
0.5 nM P4 for 16 h. The bars indicate the activity (mean ± SD; n = 3) normalized to 
uninduced levels of luciferase activity in each cell background. In WT cells 
expressing endogenous FKBP52 and FKBP51, overexpression of FKBP52 shows 
marginal increases in the reporter activity, whereas overexpression of FKBP51 
decreases reporter activity (*P < 0.05). In Fkbp52-/- cells, P4-induced reporter 
activity is minimal but restored by exogenous FKBP52 (*P < 0.05). In Fkbp51-/- cells 
retaining endogenous FKBP52, maximal reporter activity is induced; however, 
induced expression of FKBP51 decreases the activity. Statistical analysis, one-way 
ANOVA followed by paired t test. 
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(Figure 10A), and Northern blot results show that Pgr expression is not 
compromised in Fkbp52-/- uteri, but levels are rather increased (Figure 10B). This 
is also reflected by apparently increased Pgr expression in the luminal epithelium 
in Fkbp52 null uteri (Figure 10A).  Along these same lines, serum P4 levels 
between wild-type and Fkbp52 null females on day 5 of pregnancy were similar 
(Figure 10C).  Together, these results show that uterine refractoriness to 
implantation in Fkbp52-/- mice is not due to overexpression of Fkbp51, reduced 
Pgr expression, or reduced P4 levels but instead could be due to reduced PR 
function.  
 
 
 
 
 
 
Figure 10. Uterine expression of Pgr and serum P4 levels are not decreased 
in C57BL6/129 Fkbp52 null (-/-) females.  (A) In situ hybridization of uterine 
Pgr in wild-type (+/+) and -/- mice on day 4. Bar = 400 µm. (B) Northern blot 
analysis of uterine Pgr in +/+, +/-, and -/- mice on day 4. rPL7 is a 
housekeeping gene. (C) Serum P4 levels (ng/ml) in +/+ and -/- female mice on 
days 2 and 5 of pregnancy (*P < 0.05, unpaired t-test).   
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Uterine PR activity is compromised in Fkbp52-/- mice 
If FKBP52 is required for optimal PR function, then uterine PR activity 
would be compromised in the absence of FKBP52. Indeed, binding assays using 
radiolabeled P4 show that P4 binding to PR is reduced ~2-fold in Fkbp52-/- uterine 
cytosol compared with that of wild-type mice. There is also a fractional reduction 
in the number of P4 binding sites (Figure 11A). Reduced PR transcriptional 
activity in the absence of FKBP52 is also noted in a transfected cell system in 
vitro. Embryonic fibroblasts isolated from Fkbp52-/- mice were cotransfected with 
human PR-B plasmid, a luciferase reporter plasmid, and either an empty vector 
or a plasmid containing FKBP52 (p52). P4-dependent reporter activity was 
measured over a range of P4 concentrations. Cells expressing exogenous 
FKBP52 have enhanced P4-dependent reporter gene activation as compared to 
cells lacking FKBP52 (Figure 11B).  
PR-B results are shown because PR-A normally displays only modest  
reporter transactivation in cell culture systems (Daikoku et al., 2003); however, 
loss of FKBP52 did also reduce the modest activity of PR-A. These results 
provide evidence that FKBP52 is required for optimal uterine PR activity; thus, 
defects in uterine receptivity for implantation in Fkbp52-/- mice are likely caused 
by compromised uterine P4 function. 
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PR responsive genes and functions are aberrant in uteri of Fkbp52-/- mice  
We speculated that if PR functions are compromised in Fkbp52-/- uteri, 
uterine P4-dependent genes would be aberrantly expressed. We selected P4-
regulated genes that encode Hoxa-10, Indian hedgehog (Ihh), amphiregulin 
(Areg), and histidine decarboxylase (Hdc) (Das et al., 1995; Lim et al., 1999; 
Matsumoto et al., 2002; Paria et al., 1998). Wild-type and Fkbp52-/- females were 
mated with wild-type males to collect uterine samples on day 4 of pregnancy, 
Figure 11. Uterine progesterone (P4) binding and PR activity. (A) P4 binding 
in uterine cytosol of +/+ and -/- mice. Both +/+ and -/- female mice were 
ovariectomized and treated with estrogen to increase uterine PR levels. 
Uterine cytosol samples from +/+ and -/- mice were used for binding assays. 
The data shown are representative of four independent experiments. (B) 
FKBP52 effects on reporter gene activation in embryonic fibroblasts isolated 
from -/- mice cotransfected with plasmid expressing human PR-B, a 
luciferase reporter plasmid, and an empty vector or plasmid expressing 
FKBP52 (p52). Each value represents the mean ± SD for three replicate 
samples. 
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when the uterus is under major P4 influence and expresses these genes. 
Northern and in situ hybridization results show that expression of Hoxa-10, Ihh, 
and Areg are drastically down-regulated in Fkbp52-/- uteri, indicating 
compromised P4 function (Figure 12A, B & C).  As mentioned, there are two 
isoforms of PR, PRA and PRB.  Genetic studies suggest that normal P4-regulated 
ovarian and uterine functions are primarily mediated by PRA (Mulac-Jericevic et 
al., 2003). Because the mouse uterus expresses both PRA and PRB, we sought 
to examine whether FKBP52 differentially influences these isoforms. Areg and 
Hdc are known PRA and PRB regulated genes in the uterus, respectively (Mulac-
Jericevic et al., 2000). Down-regulation of both Areg and Hdc in Fkbp52-/- uteri 
(Figure 12A, B, C, & D) provides evidence that FKBP52 influences both PRA 
and PRB functions. Because mice lacking PR-B have normal fertility (Mulac-
Jericevic et al., 2003), we believe that compromised uterine PRA activity in 
Fkbp52-/- mice contributes to implantation failure. 
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Aberrant expression of estrogen-responsive gene lactoferrin in Fkbp52-/- 
uteri on day 4 of pregnancy 
 
 To confirm that the observed changes in uterine gene expression are not 
due to aberrant responsiveness of the uterus to estrogen, we examined uterine 
expression of an estrogen-responsive gene lactoferrin (Ltf) on day 1 of pregnancy 
when the uterus is primarily under the influence of estrogen (Figure 13A). As 
Figure 12. P4-regulated genes are misexpressed in C57BL6/129 Fkbp52 null 
uteri. In situ hybridization of Hoxa-10 and Ihh (A) and Areg and Hdc (B) in +/+ and 
-/- mice on day 4 of pregnancy. (C) Northern blot analysis of uterine Hoxa-10, Ihh, 
and Areg in +/+, +/-, and -/- mice on day 4. rPL7 is a housekeeping gene. le, 
luminal epithelium; ge, glandular epithelium; s, stroma. Bar = 400 µm. (D) 
Comparative RT-PCR of uterine Hdc in +/+, +/-, and -/- mice on day 4. The data 
are presented as fold changes (mean ± SEM) of three to four independent 
samples. Fold changes in Fkbp52-/- mice are significantly different compared to 
combined fold changes in +/+ and +/- mice (*P < 0.05, unpaired t test). 
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previously observed in the wild-type uterus (McMaster et al., 1992), normal 
expression of Ltf on day 1 in Fkbp52-/- uteri confirms that these null uteri 
appropriately respond to estrogen. On day 4 of pregnancy, however, when the 
uterus is under major P4 influence, Ltf expression is undetectable in wild-type 
uteri as expected, but persists in Fkbp52-/- uteri, indicating reduced P4 function 
with exaggerated estrogenic influence in the absence of FKBP52 (Figure 13A). 
 
 
 
 
 
 
 
 
Abnormal pattern of cell proliferation in Fkbp52-/- uteri on day 4 of 
pregnancy 
 
 Another striking difference was observed between wild-type and Fkbp52-/- 
uteri at the histological and cellular level. Normally, uterine lumens in wild-type 
mice on day 4 of pregnancy under P4 dominance show luminal closure with a slit-
Figure 13. Differential expression of an estrogen-responsive gene lactoferrin (Ltf) 
and cell proliferation in C57BL6/129 Fkbp52-/- uteri. (A) In situ hybridization of Ltf 
in uteri of +/+ and -/- mice on days 1 and 4 of pregnancy. Bar = 400 µm. (B) 
Histological examination of +/+ and -/- uteri on day 4 of pregnancy. Bar = 200 
µm. (C) Immunostaining of Ki67, a marker of cell proliferation, in uteri of +/+ and -
/- mice on day 4. Note stromal cell proliferation in wild-type uterus versus luminal 
epithelial proliferation in -/- mice. Arrow points to luminal epithelial layer. Bar = 
100 µm. le, luminal epithelium; s, stroma; myo, myometrium; H&E, hematoxylin 
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like structure with nonproliferating differentiated cuboidal epithelia. In addition, 
stromal cell proliferation is intense on this day (Dey et al., 2004). Surprisingly, 
uteri of Fkbp52-/- mice have compromised luminal closure on day 4, displaying 
proliferating columnar luminal epithelia and nonproliferating stromal cells, 
consistent with defects in P4-regulated events (Figure 13B & C). Collectively, 
these results suggest that responsiveness of Fkbp52-/- uteri to coordinated 
estrogen and P4 action is skewed to favor estrogen. 
 
Discussion 
The present study identifies FKBP52 as a critical determinant of uterine P4 
action in preparing the uterus receptive for blastocyst implantation. Although 
genetic and pharmacological evidence has previously established that P4 action 
via nuclear PR is essential for ovulation, implantation, and pregnancy 
maintenance, it is remarkable to see that FKBP52, an immunophilin cochaperone 
for PR, is so critical and specific to uterine preparation for implantation. 
Apparently normal ovulation and a less severe fertilization phenotype as 
compared to uterine preparation for implantation suggests differential sensitivity 
of the ovary and uterus to FKBP52-mediated P4 action. This tissue-specific 
differential sensitivity is not noted in Pgr mutant mice in which both severely 
compromised ovarian and uterine functions are responsible for female infertility. 
The physiological significance of PR-associated immunophilins had been 
underappreciated until the present study, and the dramatic infertility of mice 
lacking Fkbp52 lends credence to the significance of this immunophilin 
57 
cochaperone in female fertility. This study places FKBP52 as a target for 
improving female fertility or alternatively developing novel approaches to 
contraception.  
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CHAPTER III 
 
FKBP52 DEFICIENCY-CONFERRED UTERINE PROGESTERONE 
RESISTANCE IS GENETIC BACKGROUND AND PREGNANCY STAGE 
SPECIFIC 
 
Abstract 
Immunophilin FKBP52 serves as a cochaperone to govern normal PR function.  
Using Fkbp52-/- mice, here we show intriguing aspects of uterine P4-PR signaling 
during pregnancy.  Implantation failure is the major phenotype found in these null 
females, which is conserved on both C57BL6/129 and CD1 backgrounds. 
However, P4 supplementation rescues implantation and subsequent 
decidualization in CD1, but not in C57BL6/129, null females. Surprisingly, 
experimentally-induced decidualization in the absence of blastocysts fails in 
Fkbp52-/- mice on either background even with P4 supplementation, suggesting 
that embryonic signals complement uterine signaling for this event. Another 
interesting finding is that while P4 at higher than normal pregnancy levels confers 
PR signaling sufficient for implantation in CD1 null females, these levels are 
inefficient in maintaining the full complement of term pregnancy.  However, 
elevating P4 levels further restores PR signaling optimal for successful term 
pregnancy with normal litter size. Collectively, our results show that the 
indispensability of FKBP52 in uterine P4-PR signaling is a function of genetic 
disparity and pregnancy stage specific.  Since there is evidence for a correlation 
between P4 supplementation and reduced risks of P4-resistant recurrent 
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miscarriages and remission of endometriosis, these findings have clinical 
implications for genetically diverse populations of women.  
 
Introduction 
As mentioned, P4 signaling is an absolute requirement for implantation 
and pregnancy maintenance in most eutherian mammals studied (Dey et al., 
2004; Wang and Dey, 2006). The failure of ovulation and implantation, 
decidualization and pregnancy maintenance (Lydon et al., 1995) precludes using 
Pgr-/- mice to study potential new aspects of P4 function during pregnancy. In 
contrast, the targeted deletion of the Fkbp52 gene that encodes FKBP52, an 
immunophilin cochaperone that optimizes PR signaling, has allowed us to 
address unique aspects of uterine P4-PR signaling during pregnancy in mice 
since these mice display uterine-specific infertility (Tranguch et al., 2005).  
Our finding that Fkbp52-/- females on a C57BL6/129 mixed background 
have complete implantation failure with normal ovulation and slightly reduced 
fertilization rates has recently been confirmed by another group in independently-
generated Fkbp52-/- mice on the same genetic background (Tranguch et al., 
2005; Yang et al., 2006). The fact that the infertile phenotype of Fkbp52-/- 
females is primarily due to implantation defects suggests differential sensitivity of 
the ovary and uterus to FKBP52-PR mediated P4 action, a tissue-specific 
differential sensitivity not noted in Pgr-/- females with complete female infertility 
(Lydon et al., 1995; Mulac-Jericevic et al., 2000).  
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Although P4 is commonly known as the “hormone of pregnancy”, various 
aspects of its roles throughout pregnancy are not well understood. Therefore, 
Fkbp52-/- mice provide a unique opportunity for studying such roles of P4 
signaling throughout pregnancy.  By transferring C57BL6/129 Fkbp52-/- mice to a 
CD1 genetic background, we are able to exploit this mouse model to address 
these roles for the first time.   
 
Methods    
 
Mice  
The Fkbp52 gene was disrupted in mice by homologous recombination as 
previously described (Cheung-Flynn et al., 2005). Tail genomic DNA was used 
for PCR-based genotyping. Because genetic backgrounds of mice contribute to 
different phenotypes (Threadgill et al., 1995; Wang et al., 2004), we introduced 
Fkbp52 deficiency in CD1 mice by crossing C57BL6/129 Fkbp52 heterozygous 
males to CD1 wild-type (WT) females producing an F1 generation. F1 Fkbp52+/- 
males were then back-crossed to CD1 WT females, and the process was 
continued for ten generations. Crossing heterozygous females with heterozygous 
males of the same genetic background (CD1/F10) generated Fkbp52 WT and 
null littermates for experiments. Mice on both genetic backgrounds were housed 
and used in the present investigation in accordance with the National Institutes of 
Health and institutional guidelines on the care and use of laboratory animals. 
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Ovulation, fertilization, implantation, blastocyst transfer and 
experimentally-induced decidualization  
 
To examine ovulation and fertilization, CD1 WT or Fkbp52-/- mice were 
mated with fertile WT males. On day 2 of pregnancy (day 1 = vaginal plug), 
oviducts were flushed with Whitten's medium to recover ovulated eggs, and 
fertilization was assessed by counting the number of 2-cell embryos. Implantation 
sites on days 5 and 6 of pregnancy were visualized by an intravenous injection 
(0.1 ml/mouse) of Chicago Blue B dye solution (1% in saline) and the number of 
implantation sites as demarcated by distinct blue bands was recorded. For 
blastocyst transfer, pseudopregnant recipients were generated by mating females 
with vasectomized WT males. Day 4 WT blastocysts were transferred into day 4 
uteri of C57BL6/129 Fkbp52 WT or null pseudopregnant recipients, and 
implantation sites were observed 24 h (day 5) or 96 h (day 8) later by the blue 
dye method (Paria et al., 2001).  
To determine whether experimentally-induced decidualization occurs in 
null females, Fkbp52 WT or null females were mated with vasectomized WT 
males.  On day 4, one uterine horn was infused with sesame oil (25 µl) and the 
contralateral horn served as control. Mice were sacrificed on day 8 of 
pseudopregnancy. Uterine weights of infused (oil) and non-infused (control) 
horns were recorded, and fold increase in weight was used as an index of 
decidualization.  All mice used were between 2-5 months of age.  
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Exogenous P4 supplementation and other treatments  
To observe whether exogenous P4 treatment rescues the infertility 
phenotype of Fkbp52-/- females, null females were mated with WT males, and a 
silastic implant (4 cm length x 0.31 cm diameter) containing P4 was placed under 
the dorsal skin on day 2 of pregnancy. Implants were either removed upon 
sacrifice on days 5, 6, and 8 to examine implantation, days 12 or 14 to examine 
pregnancy maintenance or day 17 to allow labor to complete full-term pregnancy.  
For pregnancy rescue with P4 injection, null female mice were injected 
subcutaneously with P4 (2 mg/0.1 ml saline/mouse) from days 2 through 14 to 
monitor pregnancy maintenance or through day 17 to allow labor to ensue on day 
20.   
To determine contribution of complement pathway to pregnancy 
maintenance, silastic P4 implants were placed under the dorsal skin on day 2 of 
pregnancy, and heparin (10U/0.1ml/mouse in saline) was injected 
subcutaneously twice a day on days 8, 10, and 12 of pregnancy. To determine 
whether the P4 to estrogen ratio influences pregnancy maintenance, silastic P4 
implants were placed under the dorsal skin on day 2 of pregnancy and ICI 
182,780 (ICI; 25 µg or 125 µg/0.1 ml/mouse in sesame oil), an estrogen receptor 
antagonist, was injected once a day on days 8 through 13 of pregnancy.  
To determine whether exogenous P4 supplementation rescues 
experimentally-induced decidualization in null females, WT or Fkbp52-/- females 
were mated with vasectomized WT males, and P4 was either injected daily from 
day 2 or silastic P4 implants placed under the dorsal skin on day 2 of 
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pseudopregnancy. On day 4, one uterine horn was infused with sesame oil (25 
µl), and the contralateral horn served as control. Mice were sacrificed on day 8 of 
pseudopregnancy. Uterine weights of infused (oil) and non-infused (control) 
horns were recorded, and fold increase in weight was used as an index of 
decidualization. 
 
P4 assay 
Blood samples from mice were collected on the indicated days of pregnancy.  
Serum was separated by centrifugation (3,000 rpm, 15 min) and stored at -80°C 
until analysis.  Serum P4 levels were measured by radioimmunoassay (University 
of Virginia Center for Research in Reproduction, Ligand Assay & Analysis Core, 
Charlottesville, VA). 
 
In situ hybridization  
Sense or antisense 35S-labeled cRNA probes for Areg, Ihh, Hoxa10, Ltf, 
C3, Lif, Bmp2, Ptgs2, Pgr, and Fkbp52 generated by using appropriate 
polymerases from respective cDNAs were used for hybridization. Sections 
hybridized with sense probes showed no signal and served as negative controls.  
 
Immunohistochemistry  
Immunolocalization of cytokeratin was performed by using a polyclonal 
rabbit anti-cow antibody (DakoCytomation, Carpinteria, CA). A Histostain-Plus 
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(DAB) kit (Zymed) was used to visualize antigen. Brown deposits indicate sites of 
positive immunostaining.  
 
Results 
 
Implantation failure occurs in Fkbp52-/- mice irrespective of genetic 
background 
 
There is increasing evidence that mutation of a gene often results in 
altered phenotypes depending on the genetic background of mice (Threadgill et 
al., 1995; Wang et al., 2004). These varying phenotypes are thought to be due to 
differential expression and/or regulation of modifier genes (Bonyadi et al., 1997), 
although identification of such modifiers remains largely unknown. There is also 
evidence that compensatory function of genes among the same family is genetic 
background dependent (Wang et al., 2004). We have recently shown that 
C57BL6/129 Fkbp52-/- females have complete implantation failure, although 
ovulation is normal (Tranguch et al., 2005). To determine whether this phenotype 
is a function of genetic background, we established Fkbp52 deletion in CD1 mice 
(see Methods). First, we examined ovulation and fertilization in CD1 Fkbp52-/- 
females after mating with WT males since Fkbp52-/- males, irrespective of genetic 
background, are infertile (Cheung-Flynn et al., 2005; Hong et al., 2007). We 
found ovulation and fertilization in null females to be comparable with WT 
(Figure 14A & B).  CD1 Fkbp52-/- females were examined for implantation sites 
on day 5 of pregnancy by the blue dye method.  We observed that only 2 of 14 
CD1 Fkbp52-/- females showed very faint blue bands (Figure 14C & Table 6). 
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Unimplanted blastocysts were recovered from uterine flushings of null mice with 
implantation failure (Figure 14C), suggesting that although embryos developed 
to blastocysts, they fail to implant.   
 
 
 
 
 
 
 
 
 
 
 
Figure 14. P4 supplementation via silastic implants rescues implantation failure 
in CD1 Fkbp52-/- females. Ovulation (A) and fertilization (B) were examined on 
day 2 of pregnancy.  The number of ovulated eggs is not significantly different 
between wild-type (WT) and null (KO) females. Values are mean ± SE (P>0.05; 
unpaired t-test). Numbers above the bars indicate the total number of 2-cell 
embryos/total number of eggs recovered. Fertilization rate is comparable 
between WT and KO females (P > 0.05; unpaired t-test).  C. Implantation fails in 
KO females, but is rescued by P4 as examined on day 5 of pregnancy. 
Representative photographs of uteri with or without implantation sites (IS) as 
assessed by blue dye reaction in WT, KO and KO + P4 mice are shown.  
Representative photographs of blastocysts recovered from uteri of KO females 
without IS.  Arrowheads and short arrows indicate the location of ovary and IS, 
respectively.  Long arrow indicates the uterus from which unimplanted 
blastocysts were collected.  Bar = 50 µm.  
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Our data signify that optimal P4-PR signaling imparted by FKBP52 is 
critical to uterine receptivity and implantation in mice, a phenotype conserved 
across these genetic backgrounds. Because ovulation is normal in Fkbp52-/- 
mice, our results suggest that uterine responsiveness to PR signaling differs from 
that of ovarian responsiveness.  It is possible that relatively high local P4 levels in 
the ovary (Pointis et al., 1981), the site of its synthesis, enhance basal PR activity 
sufficient for ovulation and fertilization processes.   
 
Progesterone supplementation rescues implantation in CD1 Fkbp52-/- 
females 
 
We have shown that PR activity, but not PR or P4 levels, is compromised 
in C57BL6/129 Fkbp52-/- females (Tranguch et al., 2005; Tranguch et al., 2006). 
It is possible that FKBP52 binding to the PR complex modulates the hormone-
responsiveness of PR not in an all-or-none fashion, but rather to fine-tune 
physiological responses to P4.  This tenet implies that while FKBP52 is necessary 
for optimal PR activity, PR signaling can still operate, albeit not as efficiently, in 
the absence of FKBP52. 
Since serum P4 levels in CD1 Fkbp52-/- females are similar to those of WT 
on day 5 of pregnancy (Figure 15), we speculated that exposing Fkbp52-/- uteri 
to higher than normal P4 levels will enhance PR activity to rescue pregnancy 
failure in the absence of FKBP52.  This is consistent with our previous findings 
that PR activity in Fkbp52-/- mouse embryonic fibroblasts (MEFs) reached levels 
similar to those in WT MEFs exposed to higher P4 concentrations in culture 
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(Figure 10C) (Tranguch et al., 2005). This may also explain why ovulation, a P4-
regulated event, is normal in Fkbp52-/- females on both genetic backgrounds.   
 
 
 
 
To determine whether P4 supplementation rescues implantation, we used 
P4 containing silastic implants to maintain steady-state hormone levels (Milligan 
and Cohen, 1994). WT and Fkbp52-/- females were mated with WT males, and 
silastic implants containing P4 were placed under the dorsal skin of Fkbp52-/- 
females from day 2 of pregnancy until the day of sacrifice. We were surprised to 
see that P4 supplementation not only rescued implantation in CD1 Fkbp52-/- 
females examined on day 5, but the number of implantation sites was also 
comparable to those of WT mice (Figure 14C & Table 6).   
 
 
 
 
 
 
 
 
Figure 15. Peripheral serum P4 levels in CD1 WT and KO mice on day 5 of 
pregnancy. Values are not significantly different (P = 1.0, univariate ANOVA).   
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Table 6. P4 rescues implantation in CD1 Fkbp52-/- mice.  Wild-type (WT) and 
CD1 Fkbp52-/- (KO) females were mated with WT fertile males and the number of 
implantation sites (IS) was examined on days 5, 6, 8, and 12 of pregnancy.  
Fkbp52-/- females were treated with silastic implants containing P4 (KO+P4) from 
day 2 of pregnancy until the day of sacrifice.  The number and weights of IS are 
presented as mean ± SE.   
 
 
 
Genotype 
 
 
Day of 
pregnancy 
 
No. 
of 
mice 
 
No. of 
mice with 
IS (%) 
 
 
No. of IS 
 
 
Weight of IS 
(mg) 
 
No. of 
embryos 
recovered 
5 16 16 (100) 12.2 ± 0.3 4.1 ± 0.3 n/a 
6 9 9 (100 13.2 ± 0.9 10.7 ± 0.2 n/a 
8 5 5 (100) 10.8 ± 1.8 29.3 ± 1.0 n/a 
 
 
WT 
12 11 11 (100) 13.5 ± 0.8 214.7 ± 7.0 n/a 
5 14 2 (14) 7.0 ± 0.3 NE 66a 
6 9 4 (44) 4.5 ± 0.3 6.3 ± 0.1* 21b 
8 8 1 (13) 1 8.0 19c 
 
 
KO 
12 5 0 n/a n/a 0 
5 11 9 (81) 10.3 ± 0.5 3.75 ± 0.2 17d 
6 6 6 (100) 10.8 ± 1.3 7.8 ± 0.3* n/a 
8 8 8 (100) 11.4 ± 0.9 19.2 ± 0.9* n/a 
 
 
KO + P4 
12 14 14 (100) 11.6 ± 0.6 127.5 ± 8.8* n/a 
a7 mice without IS yielded 66 blastocysts of which 6 showed signs of 
degeneration 
b21 blastocysts were recovered from 5 mice of which 5 showed signs of 
degeneration 
c19 blastocysts were recovered from 3 mice of which 3 had signs of degeneration 
d17 blastocysts were recovered from 2 mice 
  *P<0.05 compared to WT; unpaired t-test. 
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In contrast, exogenous P4 supplementation was largely ineffective in 
rescuing implantation in C57BL6/129 Fkbp52-/- females; only 3 of 11 (27%) and 2 
of 8 (25%) null females showed implantation when examined on days 5 and 8, 
respectively. In addition, the number of implantation sites was also remarkably 
low, especially on day 8, compared to WT females (Table 7).  
 
Table 7.  P4 fails to rescue implantation failure in C57BL6/129 Fkbp52-/- mice.  
WT and Fkbp52-/- (KO) females on C57BL6/129 background were mated with 
WT females and the number of implantation sites (IS) was examined on days 5 
and 8 of pregnancy by the blue dye method.  Fkbp52-/- females were placed with 
P4 containing silastic implants (KO+P4) from day 2 of pregnancy until the day of 
sacrifice.  Uteri without IS were flushed with saline to recover any unimplanted 
embryos. The number of implantation sites is presented as mean ± SE. 
 
Genotype 
 
Day of 
pregnancy 
 
No. of mice
 
No. of mice 
with IS (%) 
 
No. of IS 
No. of 
embryos 
recovered 
WT 5 11 11 (100) 7.5 ± 0.5 n/a 
KO + P4 5 11 3 (27) 5.6 ± 1.0 23a 
KO + P4 8 8 2 (25)   0.5 ± 0.2* 0b 
a8 mice without IS yielded 23 blastocysts of which 21 showed signs of 
degeneration 
b6 mice without IS yielded no embryos 
 *P < 0.05 compared to WT; unpaired t-test. 
 
 
To circumvent any contribution arising from lower fertilization rates in 
C57BL6/129 Fkbp52-/- mice, we performed blastocyst transfer experiments. Day 
4 WT blastocysts were transferred into uterine lumens of day 4 C57BL6/129 
Fkbp52-/- pseudopregnant females carrying silastic P4 implants from day 2. 
Again, we noted extremely poor implantation rates in these mice (Table 8).   
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Table 8. P4 fails to rescue implantation failure of transferred WT blastocysts in 
C57BL6/129 Fkbp52-/- females. Day 4 WT blastocysts were transferred into uteri 
of WT or KO recipients on day 4 of pseudopregnancy. Fkbp52-/- females were 
treated with silastic implants containing P4 (KO+P4) from days 2 through 5 of 
pseudopregnancy.  Recipients were examined for implantation sites (IS) on day 5 
by the blue dye method.  Uteri without IS were flushed with saline to recover any 
unimplanted blastocysts. 
 
Genotype 
 
Blastocyst 
 
Recipient 
No. of 
blastocysts 
transferred
 
No. of 
recipients
No. of 
mice 
with IS 
(%) 
 
No. of IS 
(%) 
No. of 
embryos 
recovered 
WT KO + P4 82 6 6 (100) 49/82 (59) n/a 
WT KO + P4 83 5 2 (40) 6/83 (7) 45a 
a3 mice without IS yielded 45 blastocysts of which 2 showed signs of 
degeneration. 
 
 
 
P4 supplementation restores P4- and implantation-regulated gene 
expression in CD1 Fkbp52 -/- uteri 
 
P4-regulated events superimposed with preimplantation estrogen 
secretion guide the uterus from a prereceptive to the receptive state, allowing 
blastocyst attachment to the uterine wall on day 4 evening.  To determine 
whether rescue of implantation by P4 is reflected in the restoration of P4-
dependent uterine gene expression, CD1 Fkbp52-/- females mated with WT 
males were placed with a silastic P4 implant on day 2 and sacrificed on day 4 of 
pregnancy. We selected P4-regulated genes that encode Hoxa-10, Ihh, and Areg 
because of their participation in uterine receptivity (Das et al., 1995; Lee et al., 
2006; Lim et al., 1999; Matsumoto et al., 2002). In situ hybridization results show 
that exogenous P4 treatment considerably restores expression of these genes 
(Figure 16A).   
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Lactoferrin (Ltf) and complement factor 3 (C3) are highly induced in the 
uterus by estrogen and antagonized by P4 (Heikaus et al., 2002; McMaster et al., 
1992). They are abundantly expressed in the luminal epithelium on day 1 of 
pregnancy under the influence of a preovulatory estrogen surge, but are 
dramatically downregulated on day 4 by rising P4 levels from newly formed 
corpora lutea (Dey et al., 2004; Wang and Dey, 2006). However, in CD1 Fkbp52-
/- mice, uterine expression of these genes is aberrantly elevated on day 4, but 
downregulated with exogenous P4 supplementation (Figure 16B). Together, 
these findings provide evidence that P4 supplementation restores the expression 
of P4-regulated genes and counters the expression of estrogen target genes in 
CD1 Fkbp52-/- uteri, shifting the uterus to a P4-dominated milieu conducive to 
Figure 16. P4 supplementation via silastic implants corrects misexpression of 
genes in CD1 Fkbp52-/- uteri.  A.  In situ hybridization of P4-regulated genes 
Hoxa-10, Ihh, and Areg in WT, KO and KO + P4 uteri on day 4 of pregnancy  B.  
In situ hybridization of estrogen-target genes Ltf and C3 in WT, KO and KO + P4 
uteri on day 4 of pregnancy.  le, luminal epithelium; ge, glandular epithelium; s, 
stroma; myo, myometrium.  Bar, 400 µm. 
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uterine receptivity as opposed to one of estrogenic dominance that is detrimental 
to uterine receptivity.   
The fact that exogenous P4 treatment fully rescues implantation in CD1 
Fkbp52-/- females but is largely ineffective in C57BL6/129 Fkbp52-/- mice 
provoked us to examine whether P4 treatment restores the expression of P4-
regulated genes in C57BL6/129 Fkbp52-/- uteri similar to that observed in CD1 
Fkbp52-/- mice.  We found that although exogenous P4 treatment considerably 
restores Hoxa-10 and Ihh expression in mice on this genetic background, Areg 
expression remains low to undetectable with P4 treatment (Figure 17A).  More 
interestingly, exogenous P4, which normally inhibits estrogen-responsive Ltf 
expression in CD1 Fkbp52-/- uteri on day 4, was not effective in attenuating Ltf 
expression in C57BL6/129 Fkbp52-/- uteri (Figure 17B).  
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Overall, these results implicate that while C57BL6/129 Fkbp52-/- uteri are 
somewhat responsive to P4 induction of its target genes, they are less receptive 
to P4’s influence in antagonizing estrogen-target genes. These findings are 
significant, since excess estrogenic influence leads to uterine nonreceptivity (Ma 
et al., 2003).  Because implantation fails in most C57BL6/129 Fkbp52-/- mice 
even after P4 treatment, we performed subsequent experiments in CD1 Fkbp52-/- 
mice. 
Figure 17. P4 supplementation via silastic implants partially restores the expression 
of P4-target genes, but fails to counter an estrogen-responsive gene in C57BL6/129 
Fkbp52-/- uteri.  (A) In situ hybridization of P4-target genes Hoxa-10, Ihh and Areg in 
WT, KO and KO + P4 uteri on day 4 of pregnancy. (B)  In situ hybridization of an 
estrogen-target gene Ltf in WT, KO and KO + P4 uteri on day 4 of pregnancy. le, 
luminal epithelium; ge, glandular epithelium; s, stroma.  Bar = 200 µm. 
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Although expression of several P4-regulated genes is considerably 
restored with P4 supplementation in CD1 Fkbp52-/- uteri, the expression of 
leukemia inhibitory factor (Lif), normally expressed in day 4 WT pregnant uterine 
glands, is not restored by P4 treatment in these null mice (Figure 18A). We 
therefore determined whether P4 rescue of implantation on day 5 in CD1 Fkbp52-
/- mice is accompanied by correct expression of implantation-related genes, 
including Lif as well as Ptgs2 and Bmp2 (Lim et al., 1997; Paria et al., 2001; 
Song et al., 2000).  We found that while these genes are not expressed at the 
site of blastocysts in CD1 Fkbp52-/- females with failed implantation in the 
absence of P4, P4 supplementation restores implantation with correct expression 
of these genes (Figure 18A & B). The ability of P4 to rescue both implantation 
and Lif expression on day 5 of pregnancy in Fkbp52-/- mice without salvaging Lif 
expression on day 4, agrees with previous observations that the first phase of Lif 
expression on day 4 is not as critical as its second phase of expression in 
stromal cells surrounding the implanting blastocyst (Lim et al., 1997; Paria et al., 
2001; Song and Lim, 2006; Song et al., 2000).    
Upon closer examination of WT and null uterine histology, we came 
across an interesting observation. A significant decrease in the number of glands 
was noted in null uteri on both genetic backgrounds (Figure 18C). This decrease 
in gland numbers, however, does not fully account for the altered expression of 
Areg, Ihh or Lif in null uteri, since glands that are still present fail to show normal 
expression patterns of these genes.  While there is clear evidence that both 
estrogen and P4 participate in uterine gland formation in the sheep (Carpenter et 
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al., 2003; Gray et al., 2001), our data also implicate a potential role for FKBP52-
PR signaling in mouse uterine gland formation and function. This is an exciting 
finding but warrants further investigation.  
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Figure 18. Delivery of P4 via silastic implants restores expression of 
implantation-related genes in CD1 Fkbp52-/- females. (A) In situ hybridization of 
Lif in WT, KO and KO + P4 uteri on days 4 and 5 of pregnancy. (B) In situ 
hybridization of Ptgs2 and Bmp2 in WT, KO and KO + P4 uteri on day 5 of 
pregnancy. Arrowheads indicate the location of embryos.  le, luminal 
epithelium; ge, glandular epithelium; myo, myometrium. Bar = 400 µm. (C) 
Number of glands/uterine cross-section of WT and KO uteri on both CD1 and 
C57BL6/129 backgrounds.  For each animal, glands were counted from 9-12 
uterine sections.  Numbers within the bars indicate number of mice evaluated. 
Values are mean ± SE, (* P<0.05; unpaired t-test).
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Post-implantation defects in P4-treated CD1 Fkbp52-/- females 
Our observation of unimplanted blastocysts recovered from CD1 Fkbp52-/- 
females examined on day 5 of pregnancy suggested deferral of implantation 
timing in these mice as is observed in cPLA2α-/- or Lpa3-/- mice (Song et al., 2002; 
Ye et al., 2005).  To test for this possibility, CD1 Fkbp52-/- mice were sacrificed 
on days 6 and 8 of pregnancy.  We found that unlike cPLA2α-/- or Lpa3-/- mice, 
implantation timing is not altered; rather the process still drastically fails in 
Fkbp52-/- females (Figure 19A, B & Table 6). Again, blastocysts were recovered 
from CD1 Fkbp52-/- uteri on these days, confirming implantation as the major 
defect in these mice (Figure 19A, B & Table 6).    
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Figure 19. P4 delivery via silastic implants rescues blastocyst-induced, but not 
oil-induced, decidualization in Fkbp52-/- females. Representative photographs of 
WT, KO and KO + P4 uteri on day 6 (A), day 8 (B) and day 12 (C) of pregnancy 
are shown.  Arrowheads and short arrows indicate the location of ovary and IS, 
respectively. Representative images of recovered unimplanted blastocysts from 
uteri (long arrow) of KO females without IS are shown. Bar = 50 µm.  (D) 
Experimentally induced decidualization fails in KO females on both genetic 
backgrounds. Representative photomicrographs of WT, KO and KO + P4 uteri on 
day 8 of pseudopregnancy. On day 4 of pseudopregnancy, 25 µl of oil was 
infused intraluminally in one uterine horn (oil); the contralateral horn without oil 
infusion served as a control (con).  (E) Fold changes in weight between oil-
infused and non-infused control uterine horns.  Numbers above the bars indicate 
the number of mice with decidual response/total number of mice examined.   
Fold changes are presented as mean ± SE (* P<0.05; unpaired t-test).   
79 
We next determined whether P4 supplementation could sustain pregnancy 
beyond day 5. To our surprise, we found that placing silastic P4 implants in null 
females allowed progression of pregnancy in 100% of CD1 Fkbp52-/- females 
examined on days 6, 8, and 12 of pregnancy (Figure 19A, B, C & Table 6). 
However, implantation sites in P4-treated CD1 Fkbp52-/- uteri were smaller and 
weighed less than WT uteri (Table 6), suggesting a somewhat compromised 
decidual response. 
 
Experimentally-induced decidualization fails in Fkbp52-/- mice irrespective 
of P4 treatment 
 
 In pseudopregnant mice in the absence of embryos, the steroid hormonal 
milieu and responsiveness of the uterus on days 1 through 4 are similar to that of 
normal pregnancy. Various artificial stimuli, including intraluminal infusion of oil, 
can initiate many aspects of the decidual cell reaction in pseudopregnant mice if 
applied on day 4. Decidualization, characterized by stromal cell proliferation and 
differentiation into specialized types of cells with polyploidy, is critical to 
pregnancy establishment in many species (Dey et al., 2004).  Decidualization 
does not occur in Pgr-/- mice (Lydon et al., 1995; Mulac-Jericevic et al., 2000), 
demonstrating an absolute requirement for P4-PR signaling in this process.  
We asked whether experimentally-induced decidualization occurs in 
Fkbp52-/- females on both genetic backgrounds utilizing the model of intraluminal 
oil infusion and if not, whether P4 supplementation could rescue this phenotype. 
We observed severely compromised decidualization in both C57BL6/129 and 
CD1 Fkbp52-/- females when compared to WT littermates (Figure 19D & E). 
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Interestingly, P4 treatment could not restore decidualization in Fkbp52-/- mice on 
either strain with only a few swellings noted along the oil-infused uterine horn 
(Figure 19D & E).  That P4 treatment rescues blastocyst implantation with 
decidualization in CD1 Fkbp52-/- females but not experimentally-induced 
decidualization is remarkable. This may explain why gene expression differs in 
decidual beds induced by blastocysts from that induced experimentally (Bany 
and Cross, 2006).  Differences in decidualization between these two models  
also have been noted at the ultrastructural level (Lundkvist and Nilsson, 1982). 
 
P4 delivery via silastic implants partially restores full-term pregnancy in 
CD1 Fkbp52-/- females 
 
To investigate whether P4 supplementation maintains full-term pregnancy 
in CD1 Fkbp52-/- females, P4 implants placed on day 2 were removed on day 17 
since P4 withdrawal is necessary to initiate labor (McCormack and Greenwald, 
1974).  Although 9 of 13 Fkbp52-/- mothers delivered pups of normal weight, litter 
sizes were significantly smaller (Figure 20A). This provoked us to determine 
when embryonic loss occurs in null females carrying P4 implants. We observed 
that 70 of 106 implantation sites were resorbing in P4 implant-treated Fkbp52-/- 
uteri when examined on day 14, compared to only 9 of 194 in WT uteri (Figure 
20B & C).  Resorbing implantation sites in P4-treated Fkbp52-/- females appeared 
dark blue and were infiltrated with a massive number of blood cells (Figure 20B). 
In addition, cytokeratin staining of sections of implantation sites with normal 
appearance from null females carrying P4 implants showed placentas with less 
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developed and ill-defined spongiotrophoblast and labyrinth layers compared to 
those of WT females (Figure 20D).   
 
 
 
 
 
 
 
 
 
Figure 20. P4 delivery by silastic implants fails to sustain full complement of 
term pregnancy. (A) Average litter size from WT and KO + P4 mothers. Litter 
size is presented as mean ± SE (*P<0.05; unpaired t-test). (B) Representative 
photomicrographs of WT and KO + P4 uteri on day 14 of pregnancy. 
Arrowheads and arrows indicate resorbing and normal IS, respectively.  A 
representative H&E stained section of resorbing IS from KO + P4 shows 
massive infiltration of blood cells.  Bar = 200 µm.  (C) Percentage of resorption 
sites in WT and KO+P4 mice on day 14 of pregnancy (*P<0.05; unpaired t-test). 
(D) Cytokeratin staining of WT and KO + P4 IS on day 14. Bar = 200 µm.  dec, 
decidua; sp, spongiotrophoblast; lab, labyrinth. 
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Although P4-PR signaling is absolutely required for pregnancy 
maintenance in all eutherians thus far studied, uterine FKBP52 expression on 
later days of pregnancy had not yet been examined.  We found that while Fkbp52 
is expressed in the mesometrial decidua with high expression in the placenta on 
days 10 and 12 of pregnancy, Pgr is mostly expressed in the decidua (Figure 
21A & B).  
 
 
 
 
 
Embryonic signals direct normal decidual functions and development 
(Bany and Cross, 2006), which in turn govern placentation and embryonic growth 
(Bilinski et al., 1998).  Therefore, expression of Fkbp52 and Pgr in the decidua 
Figure 21. In situ hybridization of Pgr and Fkbp52 in sections of implantation 
sites (IS) on days 10 and 12 of pregnancy in CD1 Fkbp52 WT uteri shown in 
two magnifications. Bar = 200 µm (A) and 100 µm (B).  dec, decidua; pl, 
placenta. Notice heavy expression (pink signal) of Fkbp52 present in the 
placenta. 
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suggests that maternally derived FKBP52-mediated PR signaling contributes to 
feto-placental wellbeing, while placental expression of Fkbp52 suggests a PR 
independent role for FKBP52. 
 
Excessive estrogenic influence or complement activation does not 
contribute to pregnancy failure in P4 implanted Fkbp52-/- females  
 
We speculated that one possibility for the higher incidence of resorptions 
in Fkbp52-/- females carrying P4 implants is due to tipping of the balance between 
estrogen and P4 signaling towards estrogenic dominance.  Since high levels of 
estrogen are detrimental to pregnancy success (Ma et al., 2003), we examined 
whether a combined treatment of P4 implants with ICI 182,780 (ICI, 25 µg or 125 
µg/0.1ml oil/mouse, sc), an estrogen receptor antagonist (Tocris, Avonmouth, 
UK), injected on days 8-13 improves pregnancy maintenance. However, this 
combinatorial treatment of P4 with the high dose of ICI instead increased the 
resorption rate to 100% in Fkbp52-/- mice, while treatment with a lower dose of 
ICI showed resorption rates similar to those observed in null mice receiving P4 
implants alone (Figure 22). Our observation that treatment with a higher dose of 
ICI results in increased resorptions suggests that appropriate estrogen signaling 
is also critical to pregnancy maintenance. This agrees with a previous study 
showing that pregnancy maintenance under the direction of P4 is supported by 
low amounts of estrogen, especially on days 10-11 of pregnancy (Milligan and 
Finn, 1997).   
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While the underlying causes of recurrent pregnancy failure are not well 
understood, one possibility is that the maternal immune response mistakenly 
recognizes the fetus. A recent study shows that complement activation causes 
growth restriction and subsequent fetal rejection leading to pregnancy failure 
(Girardi et al., 2006).  We speculated that this pathway is activated due to 
reduced PR signaling from FKBP52 deficiency especially since P4 has anti-
inflammatory roles within and outside the uterus (Hardy et al., 2006; Tranguch et 
al., 2006).  Since low doses of heparin inhibit the complement pathway (Girardi et 
al., 2004; Girardi et al., 2006), Fkbp52-/- mice carrying P4 implants from day 2 
were given a low dose of heparin (10 U/mouse) twice a day on days 8, 10 and 12 
of pregnancy.  However, this treatment also failed to rescue pregnancy 
Figure 22. Anti-estrogen or heparin fails to rescue implantation in P4-treated 
CD1 KO mice. Representative photomicrographs of uteri on day 14 of 
pregnancy in CD1 KO mice treated with P4 -containing silastic implants from day 
2 and receiving injections of ICI 182,780 (ICI, 125µg or 25µg) or heparin (Hep, 
10 U).  Arrows denote morphologically normal implantation sites (IS) among 
numerous resorption sites. 
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maintenance in these mice (Figure 22), suggesting that activation of the 
complement pathway is not a major contributing factor for pregnancy failure in 
P4-treated Fkbp52-/- mice.   
 
Differential P4-PR signaling is required for successful full-term pregnancy 
Normal serum P4 levels during pregnancy in CD1 WT mice on days 5 and 
14 of pregnancy range between 40-47 ng/ml (Figure 15 & 23A). In our 
experiments, silastic P4 implants provided an increase in serum P4 levels 
sufficient to induce uterine receptivity and rescue implantation in CD1 Fkbp52-/- 
females, but failed to maintain full complement of term pregnancy. We 
speculated that increasing P4 levels even further would rectify this failure. We 
injected P4 subcutaneously at a dose of 2 mg/ml per mouse daily to further 
increase P4 serum levels.  We observed that in null mice, serum P4 levels 
increased to ~156 ng/ml by daily injection as compared to ~100 ng/ml in mice 
treated with P4-implants, assessed on day 14 of pregnancy (Figure 23A).  To our 
surprise, these elevated P4 levels significantly improved pregnancy maintenance 
in null females; the number and weights of implantation sites on day 14 were 
comparable to those in WT mothers (Figure 23B, C & D). Pregnancy 
maintenance in WT mice exposed to a similar P4 injection regimen was normal.  
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Our next objective was to examine whether daily P4 injections results in 
full complement of term pregnancy in null females. CD1 Fkbp52-/- females mated 
with WT males were injected daily with P4 from days 2 through 17 of pregnancy 
and monitored for term delivery on day 20. We observed that all P4-injected null 
females carried pups to term, and the average litter size was comparable to 
those of WT mothers (Figure 23E). Pup weights from null and WT mothers at the 
age of weaning and during early development were also similar (data not shown).  
 
 
 
Figure 23.  Daily P4 injections restore full complement of term pregnancy in 
CD1 Fkbp52-/- females.  (A) Serum P4 levels in WT and KO + P4 mice on day 
14 of pregnancy.   KO mice were exposed daily to P4 either via silastic implants 
(Imp) or subcutaneous injection (Inj; 2 mg/ml) from day 2 of pregnancy. Bars 
with different letters are significantly different (P<0.05, univariate ANOVA).  (B) 
Average number of IS between WT and KO + P4 Inj on day 14 is not 
significantly different (P>0.1; unpaired t-test).  (C) Weights of IS from WT and 
KO + P4 Inj mice on day 14 of pregnancy are not significantly different 
(P>0.1;unpaired t-test). (D) A representative photomicrograph of WT and KO + 
P4 Inj uteri on day 14 of pregnancy is shown. (E) The average litter size from 
WT and KO + P4 Inj mice is not significantly different (P>0.05; unpaired t-test). 
All values are mean ± SE. 
87 
Discussion 
Although P4 signaling via PR is critical for ovulation, fertilization, 
implantation, post-implantation growth and pregnancy maintenance, it is not 
known whether a similar P4-PR signaling mechanism determines these target 
and stage-specific functions or whether genetic disparity influences this signaling. 
By utilizing Fkbp52-/- females with compromised PR signaling as opposed to Pgr-
/- females with total female infertility (Lydon et al., 1995; Tranguch et al., 2005), 
we for the first time address these issues.  Our present investigations provide 
clear evidence that the major reproductive phenotype in mice missing Fkbp52 is 
unique to uterine deficiency in the context of implantation (Tranguch et al., 2005; 
Tranguch et al., 2007). The reason for the organ specific dependence on 
FKBP52 for appropriate PR signaling is not clearly understood, but is noteworthy 
since ovulation that also requires P4-PR signaling is normal in null females. It is 
possible that relatively higher P4 levels locally in the ovary override the reduced 
PR signaling in the absence of FKBP52.  This hypothesis also agrees with our 
finding that increasing P4 levels higher via injection rescues full complement of 
pregnancy, while P4 implants that increased P4 levels moderately only rescue 
pregnancy through day 12.  A proposed model for how this could occur at the 
molecular level is proposed in Figure 24.  
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We were also surprised to note that P4-PR regulated mating behavior 
appears normal, since null females mate and produce copulatory plugs. One 
possibility is that the uterus requires a more robust P4-PR signaling during 
pregnancy than other P4 targets. Alternatively, FKBP52, in addition to its role in 
influencing PR signaling, may have a unique PR-independent role in the uterus 
not observed in other tissues.  PR-independent roles for FKBP52 are now being 
examined in our laboratory. 
Figure 24. Putative model for how exogenous P4 treatment rescues PR activity 
in the absence of FKBP52. (A) In the absence of FKBP52, PR is not held in 
proper conformation to optimally bind P4, resulting in minimal PR-mediated 
response to ligand.  (B) In the presence of FKBP52, PR is held in proper 
conformation and efficiently binds hormone for optimal P4-PR signaling. (C) In 
the absence of FKBP52 but with exogenous ligand, even though PR is not held 
in the optimal conformation for ligand binding, the increased ligand availability 
increases its probability of binding to PR, resulting in P4-PR signaling analogous 
to (B). 
89 
P4 signaling via PR plays major roles at essentially all stages of pregnancy 
from ovulation through parturition.  It is surprising to see that genetic makeup of a 
species alters such a fundamental signaling pathway. While FKBP52 is essential 
to support implantation in both strains of mice in the absence of exogenous P4, 
FKBP52’s role becomes less significant in CD1 mice exposed to high levels of 
P4, while still remaining crucial in C57BL6/129 mice under similar treatment 
conditions. The contrasting reproductive phenotypes of Fkbp52-/- mice on 
C57BL6/129 and CD1 backgrounds with respect to P4 rescue indeed provides 
first evidence that P4-PR-FKBP52 signaling is a function of genetic makeup.   
Coordinated interactions of P4 and estrogen are essential to uterine 
receptivity and implantation. While one aspect of P4 signaling is to correctly 
orchestrate P4-responsive genes, another aspect is to appropriately constrain 
and/or synergize estrogen-responsive genes in the uterus.  One cause of 
implantation failure in C57BL6/129, but not in CD1, Fkbp52-/- females 
supplemented with P4 could be due to the failure of the uterus to attain optimal 
receptivity arising from altered expression of Areg and/or Ltf. This inappropriate 
gene expression in the presence of P4 may reflect even lower basal PR activity in 
C57BL6/129 Fkbp52-/- uteri compared to CD1 Fkbp52-/- uteri. Alternatively, 
differential expression of modifier genes in these two strains of mice could 
contribute to differential uterine responsiveness to P4-PR signaling in the 
absence of FKBP52. 
There is evidence that rodent blastocysts synthesize P4 or structurally 
similar steroids (Carson et al., 1982; Wu, 1987; Wu and Liu, 1990) and that gene 
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expression differs in embryo-induced decidua versus experimentally induced 
deciduoma (Bany and Cross, 2006).  Since our previous results show that 
Fkbp52 and Pgr are expressed in blastocysts (Tranguch et al., 2005), it is 
possible that P4 synthesized from blastocysts enhances PR-FKBP52 signaling 
locally at their sites of apposition in the uterus. This could explain failure of oil-
induced decidualization but not of that induced by implanting blastocysts in CD1 
Fkbp52-/- mice supplemented with P4.  Alternatively, signaling arising from 
blastocysts may influence other uterine functions.  For example, the gene 
encoding heparin-binding epidermal growth factor-like growth factor (Hbegf) is 
induced in implantation-competent blastocysts which can induce uterine Hbegf to 
initiate the implantation cascade. In fact, Affi-Gel Blue beads presoaked in rHB-
EGF, when transferred into uterine lumens of pseudopregnant mice on day 4, 
show implantation-like responses similar to those induced by living blastocysts 
including upregulation of Hbegf and Bmp2 (Hamatani et al., 2004; Paria et al., 
2001).   
P4-PR signaling is critical throughout pregnancy until its downregulation for 
the onset of parturition. Indeed, ovariectomizing mice practically at any stage of 
pregnancy causes resorptions and/or abortion (Sharma and Bulmer, 1983).  
However, the magnitude of this signaling during various stages of pregnancy 
remains unknown. The use of Fkbp52-/- females has enabled us to show that the 
requirement for P4-PR signaling is different for uterine receptivity, implantation 
and post-implantation growth. This signaling appears tightly regulated since 
blood levels of ~100 ng/ml of P4 are adequate to induce uterine receptivity and 
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implantation, but levels above 150 ng/ml are required for full complement of 
pregnancy success in the absence of FKBP52. This suggests that a more robust 
P4-PR signaling is required for pregnancy maintenance than is required for 
uterine receptivity, implantation and decidualization. It is also possible that a 
burst of P4 levels as provided by daily injections is more amenable to pregnancy 
sustenance than the relatively constant levels maintained with silastic implants.   
The observation that differential P4 levels are required for various stages 
of pregnancy insinuates that signaling targets are different. We believe that P4-
PR signaling for uterine preparation, implantation and decidualization is primarily 
targeted to uterine epithelial and stromal cells. This is consistent with P4’s known 
roles in epithelial differentiation and stromal cell proliferation during the 
periimplantation period. On the other hand, P4-PR signaling for pregnancy 
maintenance is directed more towards keeping the myometrium quiescent until 
parturition and providing sanctuary to the growing fetus from mother’s 
immunological surveillance.  P4-PR signaling is also known to regulate 
angiogenesis (Ma et al., 2001), a process integral to placental development and 
pregnancy maintenance. Since the events during the course of pregnancy are 
very dynamic, P4-PR signaling at various targets could be overlapping. We 
consider FKBP52’s influence on P4-PR signaling during pregnancy primarily to 
be of maternal origin, since both PR and FKBP52 are expressed in the decidua 
on days 10 and 12 of pregnancy.  The high expression of FKBP52 in the 
placenta implies a PR-independent role for FKBP52 in placentation.  This 
requires further investigation, but this putative PR-independent role is not critical 
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since pregnancies are completed to term with normal litter sizes in CD1 Fkbp52 
null females receiving daily P4 injections. 
An interesting observation is the successful nursing of pups to weaning by 
P4-injected CD1 Fkbp52-/- mothers.  Mammary morphogenesis during pregnancy 
requires P4-PR signaling (Mulac-Jericevic et al., 2003; Mulac-Jericevic et al., 
2000), but the latter stages of lactogenesis and lactation correspond to 
withdrawal of this signaling (Neville et al., 2002).  It was recently reported that 
FKBP52 may not be critical for P4-PR signaling in the mammary gland, since 
exogenously provided P4 could stimulate mammary morphogenesis in Fkbp52-/- 
mice (Yang et al., 2006).  This is similar to our studies in which Fkbp52-/- mothers 
were injected with exogenous P4 prior to parturition. These results suggest that 
exogenously supplemented P4 overcomes the P4-resistant state in the mammary 
gland and uterus in the absence of FKBP52.   
The implanting blastocyst is the stimulus for normal decidualization in 
mice.  However, in humans, stromal cells undergo decidualization during the 
receptive phase in each menstrual cycle in the absence of blastocysts. This pre-
decidualization is thought to be critical for blastocyst implantation in the pregnant 
uterus (Chobotova et al., 2005).  Our findings that P4 supplementation fails to 
rescue oil-induced decidualization in Fkbp52 null uteri may therefore have 
implications for pre-decidualization events in P4-resistant women.  
P4 resistance is also a hallmark of endometriosis, a condition that affects 
an estimated 5 million women in the United States alone (Berkley et al., 2005; 
Bulun et al., 2006; Fang et al., 2004). In fact, a recent study examining global 
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gene expression profiles in endometria of women with or without endometriosis 
found dysregulation of many known P4-target genes during the window of uterine 
receptivity (Kao et al., 2003).  While the mechanism(s) of P4 resistance remain 
unclear, one speculation is that downregulation of PR contributes to P4 
resistance, but other studies refute this concept (Bulun et al., 2006). Whether 
FKBP52 expression differs in normal and endometriotic tissues has not been 
examined.  However, the finding that human FKBP52 interacts with and 
potentiates human PR activity in mouse embryonic fibroblasts (Tranguch et al., 
2005), and our preliminary observation on a limited number of samples showing 
FKBP52 and PR expression in human endometria in proliferative and secretory 
phases (Figure 25A & B) suggest a potential role for uterine P4-PR-FKBP52 
signaling in women. 
  
 
 
 
 
 
 
 
 
In fact, three separate clinical trials found that P4 treatment resulted in a 
statistically significant decrease in miscarriages in women with history of three or 
Figure 25. PR and FKBP52 expression in human proliferative (A) and secretory 
(B) endometrium shown at two magnifications. Bar = 100 µm (A) and 200 µm 
(B). 
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more consecutive pregnancy losses (Oates-Whitehead et al., 2003).  In this 
respect, pregnancy rescue in CD1 Fkbp52-/- mice by daily P4 injections is 
clinically relevant for women who are infertile due to P4 resistance.  These are 
exciting results especially since no significant differences in adverse effects were 
found between P4 treatment and control groups. These findings in humans are 
similar to our findings in mice that exogenous P4 injections in WT females do not 
adversely affect pregnancy.  Fkbp52 null mice with normal PR and P4 levels but 
reduced PR activity constitute a unique model to study P4 resistance specifically 
in uterine biology, and our findings hopefully will encourage human studies to 
determine whether FKBP52 status influences P4 resistance in the uterus. 
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